rfhg_200108.1

Basic information about the TSS

---

TSS ID: rfhg_200108.1 TSS ID(Version3): hg_168756.1 Species: human Chr: chr17		Start: 81512764 End: 81512837 Strand: -
Source datasets	FANTOM5|EPD|DBTSS|DRA000914|ENCODE|RAMPAGE|PRJNA548673 |PRJNA615891|PRJNA401781|PRJDB5282|PRJNA4843412|DRA013844 |PRJNA597322
Protocol	CAGE|TSS_database|TSS-seq|RAMPAGE|ReCappable-seq|TIF-seq2 |SLIC_CAGE|C1CAGE|NETCAGE|STRIPE-seq|oligo_capping
TSS cluster detected*	17

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2971028,EH38E1892355)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000573283.7:0 ENST00000570382.2:0 ENST00000680227.1:0 ENST00000681092.1:0 ENST00000575842.5:0 ENST00000576917.5:0 ENST00000575087.5:0 ENST00000571721.6:0 ENST00000571691.6:0 BC053572:0 BC015005:0 BC009848:0 BC007442:0 BC012050:0 BC015695:0 BC018774:0 X04098:0 BC010999:0 BC000292:0 AK301175:0 AK291937:0 AK304637:0 GeneID: 71 HGNC/MGI_ID: HGNC:144 UniProt_ID: B4DVQ0 B4E3A4 I3L3R2 I3L4N8 K7EM38 P63261 Nearer transcript ids and distances: ENST00000644774.2:1 BC015779:2 BC001920:9 ENST00000681842.1:-10 ENST00000576544.6:-14 ENST00000574671.6:-14 ENST00000576214.3:-14 ENST00000679410.1:-14 ENST00000572105.7:-14 ENST00000679535.1:-14 ENST00000679480.1:93 ENST00000680727.1:260 BT019856:410 DQ891374:410 KJ896370:410 KJ905681:410 KR711165:410 KR711166:410 KR711167:410 KR711168:410 EU176631:410 EU832621:410 EU832693:410 KJ904414:410 CU676328:410 CU680176:410 BC063495:419 DQ589977:432 BC004223:433 BC017450:459 view more...

Gene_name: actin gamma 1 Gene_symbol: ACTG1 Gene_synonyms: Gene_source: HGNC:144

TATA-Box annotation

---

Distance to TSS:	-1
Nearest PromoterID:	NM_001614
Entrez ID:	71
Nearest Unigene:	Hs.514581
Nearest Refseq:	NM_001614
Nearest Ensembl:	ENSG00000184009
Gene Name:	actin gamma 1
Gene Alias:	ACT|ACTG|DFNA20|DFNA26|HEL-176
Gene Type:	protein-coding
CpG%:	0.123288
GC%:	0.635135
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):	5(GCTTAAATAACG,+,0.00)

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ACTG1 p2@ACTG1 p3@ACTG1 p4@ACTG1 p6@ACTG1 p7@ACTG1 p8@ACTG1 p9@ACTG1 p10@ACTG1
Sample		p1@ACTG1	p2@ACTG1	p3@ACTG1	p4@ACTG1	p6@ACTG1	p7@ACTG1	p8@ACTG1	p9@ACTG1	p10@ACTG1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	7709.93	72.27	11.10	8.96	7.01	5.06	3.70	1.95	4.09
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	8399.45	52.20	8.30	10.12	5.87	3.24	2.23	1.01	1.42
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	8726.59	58.64	11.00	10.42	4.24	3.28	3.47	0.96	1.93
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	7075.80	48.03	9.36	4.99	2.91	3.12	1.04	1.66	1.66
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	6955.28	47.02	8.55	9.22	1.35	2.92	1.80	0.67	1.57
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	7327.58	38.76	7.36	6.40	4.07	3.10	1.74	1.55	2.33
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	6400.32	46.19	13.94	7.41	4.14	3.92	4.14	2.18	1.96
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	6566.82	50.14	9.93	7.02	2.66	7.02	2.42	1.45	2.91
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	6500.84	47.02	9.83	5.56	1.92	2.14	1.07	0.43	1.92
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	2004.35	11.01	2.90	3.48	2.90	1.74	0.58	1.74	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	1800.05	10.91	1.62	1.21	0.40	0.40	0.40	0.81	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	1883.15	13.01	1.22	1.22	3.25	0.00	0.00	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	11255.28	114.61	39.33	27.40	28.05	14.67	11.28	13.38	4.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	11828.64	146.44	49.47	36.99	24.06	13.23	11.43	15.19	7.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	10276.19	109.78	32.27	30.08	20.20	10.98	9.66	7.25	6.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	11471.99	145.11	44.26	35.21	27.66	18.36	16.35	16.35	10.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	11818.44	108.77	32.76	31.01	20.09	9.61	8.74	7.86	5.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	12656.61	124.01	43.87	32.48	28.68	13.92	15.19	14.76	5.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	12548.86	127.96	50.65	21.86	17.06	11.73	13.86	10.66	5.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	11113.27	133.74	42.88	33.10	25.73	12.64	11.13	13.99	6.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	11041.78	104.11	36.89	30.61	27.00	11.23	10.69	11.23	4.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	11750.82	122.39	40.91	30.55	25.38	12.77	11.74	9.84	3.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	10908.00	126.03	42.40	29.86	25.33	11.12	10.73	11.37	5.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	10171.66	111.14	32.27	27.42	28.88	15.77	10.43	12.38	4.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	11568.78	107.32	36.89	25.80	19.61	12.13	11.87	8.51	5.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	11397.28	87.99	28.80	26.90	21.52	14.24	6.33	10.76	3.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	12783.73	112.09	37.36	29.12	13.74	14.84	12.64	12.64	4.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	13658.58	143.34	38.90	33.24	25.46	9.90	10.37	11.32	7.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	12582.20	119.20	32.47	36.99	21.97	9.85	13.73	10.82	4.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	11253.89	123.06	36.74	40.90	27.33	13.75	13.03	9.77	3.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	11716.55	112.84	32.03	27.42	22.82	16.33	10.47	12.98	6.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	11869.83	106.87	28.92	29.70	23.25	12.70	10.94	9.38	3.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	14177.79	123.87	33.55	31.02	21.95	10.13	10.13	13.08	5.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	14107.30	133.60	41.23	38.60	20.78	13.85	14.02	16.33	6.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	11144.40	139.87	35.15	40.39	25.43	14.02	13.09	15.15	6.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	11003.58	117.66	35.83	38.71	22.61	12.65	10.35	8.62	5.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	10897.34	122.42	30.66	39.45	23.50	12.88	11.85	13.90	4.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	11786.78	152.53	39.49	46.74	29.62	15.31	15.51	16.12	6.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	11210.88	145.05	33.76	32.95	20.26	14.59	14.32	14.86	7.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	10415.33	102.03	27.37	29.05	17.04	10.80	10.80	8.16	5.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	10636.33	100.93	29.17	25.88	20.47	11.29	9.18	10.59	3.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	11304.86	123.12	31.47	27.38	17.57	14.35	11.13	11.71	4.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	9834.81	137.92	39.23	32.27	27.84	13.92	13.29	11.81	6.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	10542.61	120.46	33.39	31.29	22.55	13.81	9.27	12.76	5.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	9916.97	119.66	37.14	26.30	23.89	13.25	9.84	10.24	6.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	9605.73	130.05	42.34	36.99	31.17	17.45	11.40	19.08	5.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	10022.80	104.36	27.35	29.75	23.51	10.56	5.76	8.16	4.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	9725.07	83.75	23.84	26.53	21.16	7.45	7.75	8.64	6.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	9703.27	96.71	27.53	19.63	22.98	11.25	7.42	7.18	3.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	10227.34	95.03	28.11	21.03	23.25	8.09	8.09	6.67	4.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	9832.04	231.80	63.54	22.75	27.87	12.30	9.84	7.79	11.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	10646.39	155.66	47.37	23.35	26.02	11.56	5.34	5.11	9.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	2014.87	97.95	13.99	55.97	13.99	13.99	13.99	13.99	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	12337.71	202.98	45.07	38.32	20.58	13.48	8.16	6.03	10.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	10307.37	181.27	45.40	35.79	21.54	14.25	8.95	7.62	7.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	4739.16	141.78	55.37	29.36	20.13	6.71	16.78	6.71	5.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	8031.68	175.89	52.81	18.83	19.75	8.27	8.73	7.81	11.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	9870.07	195.11	50.89	43.11	28.52	15.56	11.02	9.40	9.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	9293.04	125.26	34.04	28.91	17.34	6.42	7.39	6.42	4.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	7573.16	158.42	51.86	34.26	21.69	12.57	10.69	5.66	8.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	9999.78	153.70	35.25	32.43	11.99	15.51	6.35	2.82	4.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	9778.46	143.56	41.50	37.01	17.95	11.22	10.09	6.17	5.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	4673.36	112.26	84.39	13.53	30.25	6.37	5.57	3.18	22.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	7004.99	124.02	40.77	29.22	20.39	7.47	6.46	4.42	7.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	8490.83	147.84	50.36	36.39	31.52	17.87	8.77	8.77	7.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	8150.33	117.85	36.92	29.11	28.75	8.52	6.74	7.10	5.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	1567.90	64.66	32.33	16.16	0.00	0.00	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	1966.47	55.28	31.59	23.69	0.00	0.00	15.79	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	8393.07	119.93	44.36	26.81	27.79	12.68	9.26	8.29	6.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	8723.37	139.84	27.77	31.74	22.81	7.93	5.95	5.45	8.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	8297.22	96.17	29.09	15.95	12.67	6.57	3.75	3.28	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	4012.35	60.28	15.57	14.24	7.29	7.95	5.96	1.99	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	5106.92	105.49	34.65	24.75	22.27	12.37	11.45	4.95	4.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	5216.61	66.35	19.26	19.87	15.59	7.03	6.11	3.67	2.14
Adipocyte - breast, donor1	11376-118A8	7510.25	49.26	10.29	7.13	7.76	6.81	1.74	3.33	0.95
Adipocyte - breast, donor2	11327-117E4	5326.01	97.22	41.71	20.37	14.44	6.90	4.49	2.73	3.85
Adipocyte - omental, donor1	11473-119C6	5768.75	36.77	10.05	7.00	8.02	4.58	1.27	4.71	1.53
Adipocyte - omental, donor2	11474-119C7	7056.33	74.75	14.95	44.85	5.23	8.97	4.48	2.99	4.48
Adipocyte - omental, donor3	11475-119C8	4874.42	63.97	8.71	23.11	9.71	4.69	2.68	1.00	1.34
Adipocyte - perirenal, donor1	11476-119C9	4277.09	66.99	12.12	17.23	9.57	4.47	1.28	3.19	4.47
Adipocyte - subcutaneous, donor1	11259-116F8	4019.79	36.28	5.50	16.49	3.30	5.50	3.30	5.50	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	3720.48	27.55	2.71	3.61	2.26	0.00	0.90	1.35	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	2264.30	20.68	5.56	6.95	1.91	2.26	1.91	3.65	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	2345.49	15.65	2.74	2.15	1.56	0.20	0.59	0.98	0.98
Adipocyte differentiation, day04, donor2	13022-139D7	2163.01	11.84	2.32	1.80	1.54	0.51	1.29	0.26	1.29
Adipocyte differentiation, day04, donor3	13025-139E1	2572.51	12.27	2.23	1.95	1.95	0.28	0.00	0.84	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	2451.17	10.58	0.59	2.35	1.18	0.59	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	677.97	3.14	1.21	0.40	0.40	0.48	0.48	0.16	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	1468.21	9.68	1.29	1.94	0.97	0.65	1.29	0.97	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	1859.23	24.53	5.87	11.73	4.27	3.20	0.53	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	1475.11	10.57	0.00	0.56	1.11	0.00	0.00	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	833.45	4.99	0.42	0.83	0.00	0.42	0.42	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	1270.65	10.80	0.75	1.76	0.75	0.75	0.25	0.50	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	1286.07	9.49	1.64	0.98	0.33	0.33	0.33	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	873.22	3.35	0.00	0.30	0.91	0.30	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	16962.89	26.74	7.96	4.86	7.29	1.33	1.99	1.10	2.21
Alveolar Epithelial Cells, donor2	11590-120G6	13448.61	131.96	22.59	35.86	10.76	12.19	12.55	2.51	6.45
Alveolar Epithelial Cells, donor3	11671-122G6	5583.95	41.93	5.99	4.79	3.59	2.40	5.99	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	8492.62	9.00	2.16	2.70	1.44	1.62	1.08	0.36	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	5960.99	8.37	5.02	1.67	3.35	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	8377.73	30.61	8.01	6.37	6.16	3.08	2.05	2.05	1.03
Anulus Pulposus Cell, donor1	11248-116E6	4144.85	18.31	5.49	4.81	2.86	3.32	1.72	1.95	1.03
Anulus Pulposus Cell, donor2	11463-119B5	3446.82	25.23	6.61	9.80	4.65	5.39	1.71	1.96	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	3677.48	84.47	15.28	6.29	3.59	4.94	8.09	0.90	3.15
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	4565.86	82.05	10.42	8.25	4.78	3.47	6.51	2.17	1.74
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	5207.22	92.03	23.54	6.42	8.56	2.14	2.14	6.42	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	3912.59	93.26	16.44	8.97	4.18	3.59	5.98	2.09	2.69
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	4136.68	115.08	24.03	16.44	3.79	6.32	7.59	2.53	8.85
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5112.90	44.22	11.88	6.60	5.94	4.62	3.30	1.98	1.98
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	3713.12	60.75	10.72	13.32	3.57	3.25	2.92	0.32	1.95
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	3974.30	62.14	11.17	10.68	5.83	5.83	3.40	0.97	2.43
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	5324.72	80.17	19.60	14.85	8.91	7.13	2.97	2.38	3.56
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	3854.88	84.74	15.07	17.70	4.52	6.03	5.27	5.65	3.77
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	3520.24	56.60	7.26	9.43	3.63	2.18	5.08	3.63	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	4951.16	67.70	11.28	13.79	12.54	7.52	1.25	8.78	5.02
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	4867.13	15.32	5.27	3.46	3.13	1.15	0.82	1.32	1.65
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	2287.41	66.88	9.55	5.46	2.73	2.73	5.46	2.73	5.46
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	5149.06	11.16	4.98	4.07	4.07	3.02	2.56	1.06	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	3802.48	76.08	13.93	8.04	4.82	4.82	2.14	4.82	2.68
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	4707.52	47.80	11.15	11.90	6.23	4.72	2.83	2.08	1.51
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	5414.42	75.11	15.77	8.29	6.41	4.54	4.28	3.47	4.81
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	2298.16	55.60	9.75	1.95	2.93	0.98	3.90	1.95	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	4664.47	42.63	9.95	12.61	4.98	5.14	4.64	1.49	1.82
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	5190.73	85.25	20.41	13.21	8.41	2.40	4.80	4.80	3.60
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	1306.32	67.26	10.62	0.00	0.00	0.00	3.54	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	4650.35	45.11	9.43	14.24	7.55	3.60	4.46	2.40	2.06
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	5298.24	88.09	8.39	8.39	8.39	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	4043.10	90.29	15.05	10.19	6.80	3.40	3.40	1.46	5.34
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	5301.31	61.09	7.59	14.42	5.69	7.21	8.73	4.17	4.93
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	5188.28	87.22	21.80	3.63	2.42	4.85	4.85	2.42	6.06
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	3914.42	83.22	6.27	7.41	6.27	0.57	4.56	2.28	2.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	4604.07	46.39	11.12	11.33	6.84	4.49	4.28	2.78	1.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	4848.48	44.13	14.97	8.52	6.19	5.94	3.61	1.81	3.10
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	4332.18	58.18	12.20	10.32	7.04	3.75	5.63	1.88	3.75
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	4620.02	53.70	9.00	10.93	5.14	3.86	5.47	1.29	2.25
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	5138.99	49.23	9.27	7.13	2.85	2.85	4.28	0.71	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	4047.86	62.59	10.53	12.28	4.09	2.34	7.02	2.34	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	4611.53	55.70	10.24	8.43	6.02	5.12	4.22	1.81	1.81
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	5559.79	78.41	11.88	7.13	4.75	4.75	3.56	7.13	4.75
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	4454.98	107.81	13.22	18.82	8.14	7.63	7.12	5.09	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	4678.36	73.10	11.97	14.26	6.11	8.15	6.37	6.11	1.78
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	5032.75	50.19	13.34	5.08	6.35	5.08	1.91	1.91	3.18
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	4094.82	71.20	14.24	9.93	3.45	5.18	4.75	1.73	3.02
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	4689.90	43.61	9.31	14.18	5.50	3.39	3.81	2.96	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	4724.96	47.27	7.83	7.25	4.93	4.06	3.48	4.93	1.16
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	3333.97	73.69	15.12	5.67	2.83	3.78	2.83	0.00	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	4718.21	36.11	11.02	11.87	7.29	3.56	4.75	1.36	1.36
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	5559.28	67.17	18.53	4.63	6.95	4.63	0.00	11.58	6.95
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	1679.49	73.94	6.34	0.00	6.34	0.00	2.11	0.00	4.23
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	4851.07	59.61	10.72	11.79	6.22	6.22	3.43	2.14	2.14
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	5094.29	59.56	19.85	3.61	4.81	4.81	4.81	4.21	2.41
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	3649.26	91.12	13.12	7.29	6.56	5.83	6.56	1.46	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	4867.27	56.32	14.25	16.78	4.14	4.83	5.06	2.53	2.53
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5057.24	104.56	17.85	10.20	12.75	2.55	2.55	2.55	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	4735.56	9.41	2.54	2.54	3.81	1.78	1.53	1.27	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	4851.12	57.60	12.80	9.70	7.64	4.54	4.34	2.68	1.24
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	4889.58	51.41	11.32	6.73	6.12	2.75	3.06	3.06	2.75
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	3906.79	88.43	14.82	18.16	4.78	6.21	5.26	4.78	1.91
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	4427.70	44.57	7.54	10.20	5.54	4.66	5.10	4.21	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	4879.50	86.97	16.78	7.63	4.58	4.58	7.63	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	3477.86	50.96	3.88	7.75	7.20	3.32	1.66	1.66	1.66
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	4226.38	50.31	13.50	10.59	4.50	3.71	3.97	2.38	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	4763.70	49.07	13.45	13.08	2.91	5.82	1.45	1.45	2.54
Astrocyte - cerebellum, donor1	11500-119F6	20403.49	28.37	7.25	4.42	5.28	2.82	3.07	0.25	1.23
Astrocyte - cerebellum, donor2	11580-120F5	14455.82	95.68	12.84	23.28	11.81	7.19	8.39	2.74	2.74
Astrocyte - cerebellum, donor3	11661-122F5	8622.71	50.13	10.70	10.07	5.45	4.19	2.52	1.89	2.94
Astrocyte - cerebral cortex, donor1	11235-116D2	6773.36	13.59	7.67	4.88	2.09	2.09	1.05	1.05	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	6500.23	89.95	26.05	13.91	8.90	4.85	6.79	5.66	4.04
Astrocyte - cerebral cortex, donor3	11392-118C6	12890.13	87.86	29.98	22.82	13.72	6.56	8.80	4.18	3.28
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	5151.67	65.60	20.87	10.44	5.39	3.44	2.52	3.33	2.52
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	5995.36	54.12	15.79	9.65	6.89	3.26	3.01	1.88	2.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	5319.53	48.36	13.66	5.23	4.10	1.59	2.50	1.25	3.19
Basophils, donor1	12241-129G9	1973.79	2.62	0.78	0.78	0.78	0.52	0.00	0.26	0.26
Basophils, donor2	12242-129H1	3661.35	3.25	0.72	0.36	0.36	0.36	1.08	0.36	0.36
Basophils, donor3	12243-129H2	1792.78	4.26	1.32	1.32	1.18	0.88	0.29	0.15	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	6604.35	16.82	2.59	3.02	2.16	1.29	0.86	0.43	1.29
Bronchial Epithelial Cell, donor2	11591-120G7	11112.36	78.18	12.80	30.17	13.72	5.94	4.57	0.91	3.20
Bronchial Epithelial Cell, donor3	11672-122G7	2812.04	35.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	7083.69	72.18	15.06	12.55	10.67	4.39	2.51	0.00	4.39
Bronchial Epithelial Cell, donor5	11457-119A8	8404.11	77.57	18.72	29.74	9.98	5.61	5.61	2.70	3.54
Bronchial Epithelial Cell, donor6	11461-119B3	3424.42	37.54	13.36	8.75	6.22	1.61	2.30	0.46	1.84
Bronchial Epithelial Cell, donor7	11769-123I5	2631.70	32.39	5.94	6.84	2.34	2.16	1.80	1.62	1.08
Burkitt's lymphoma cell line:DAUDI	10422-106C8	2302.05	3.92	1.65	1.13	1.24	0.21	0.62	0.21	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	2406.83	2.33	1.40	0.93	0.70	0.23	0.70	0.23	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	3620.81	5.76	1.60	4.16	0.96	0.64	1.28	0.64	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	5977.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	1429.74	3.94	1.13	0.56	1.69	0.00	0.56	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	2327.25	19.67	4.08	1.48	0.93	0.74	1.30	0.19	0.74
CD14+ Monocytes, donor3	11381-118B4	1457.50	10.32	3.07	1.32	0.66	0.88	0.44	0.66	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	757.71	6.79	0.57	0.85	1.13	1.98	0.57	0.28	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	1123.20	7.58	1.90	0.38	0.76	0.76	0.38	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	960.91	7.23	0.66	0.33	0.66	2.63	0.00	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	2034.24	38.02	11.27	5.78	4.19	1.16	1.73	1.73	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	2256.13	24.74	6.34	2.41	3.02	1.51	0.60	0.00	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	1647.59	19.19	3.79	4.97	3.55	1.42	0.95	0.95	1.66
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	2717.70	36.16	13.06	4.52	5.86	1.51	2.01	1.00	1.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	3447.66	32.02	9.38	4.14	3.31	0.83	0.28	0.83	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	3356.96	27.77	4.96	4.21	2.48	1.24	1.74	1.24	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	2633.72	37.40	11.75	6.85	6.66	2.55	3.13	1.57	1.17
CD14+ monocytes - treated with BCG, donor2	11870-125B7	2621.41	29.73	8.37	3.03	2.31	1.07	1.25	0.53	1.60
CD14+ monocytes - treated with BCG, donor3	11880-125C8	2608.73	17.63	5.01	4.35	2.83	2.83	0.87	1.09	2.61
CD14+ monocytes - treated with Candida, donor1	11868-125B5	1802.54	22.24	6.79	3.04	3.51	1.17	0.70	0.94	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	2686.61	24.82	3.17	2.11	4.75	2.11	1.58	0.53	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	1736.14	12.20	2.22	3.33	1.11	0.00	1.11	0.00	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	2411.36	40.61	11.90	5.95	5.80	3.27	2.38	1.78	1.04
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	2892.24	33.52	8.98	3.19	4.99	1.80	0.80	0.40	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	2676.19	15.41	7.08	4.58	1.67	1.04	1.25	0.62	1.67
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	3520.08	62.00	18.30	9.15	7.09	7.09	5.03	2.29	3.66
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	3860.40	24.43	2.71	0.90	0.90	0.68	0.00	0.00	1.81
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	2242.54	36.23	7.42	5.67	0.87	2.62	0.44	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	1207.76	23.13	2.96	2.96	2.15	1.08	0.27	0.54	1.34
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	1642.02	18.14	6.46	3.14	3.49	1.22	0.52	0.52	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	1126.96	19.78	3.79	3.79	2.95	0.84	0.84	0.84	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	3143.29	40.78	9.92	6.98	4.78	1.84	1.47	1.65	1.47
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	4179.63	30.65	4.93	3.52	2.82	1.06	0.00	0.00	1.76
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3041.68	26.76	15.79	6.58	7.90	1.32	0.44	0.00	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	2223.27	32.43	8.89	5.06	5.06	0.87	2.79	1.39	0.87
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	2409.95	24.90	5.20	3.35	2.60	0.74	0.74	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	2562.67	18.97	6.47	3.02	2.37	0.86	0.65	0.43	1.72
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	2367.66	32.76	7.78	6.55	3.28	2.87	0.41	1.23	2.87
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	3491.36	8.81	1.62	1.16	1.16	0.23	0.23	0.23	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	2169.82	12.30	4.64	2.78	1.16	1.16	1.62	0.23	1.39
CD14+CD16+ Monocytes, donor1	11789-124B7	1870.13	12.86	3.49	2.40	1.31	0.00	0.44	0.22	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	3163.47	11.78	5.54	3.46	1.39	1.39	2.08	0.46	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	1512.41	2.38	0.87	1.30	0.22	0.65	0.22	0.43	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	2382.39	10.59	4.52	1.71	0.62	0.62	1.56	0.93	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	3271.44	8.91	3.49	1.22	1.57	0.52	0.52	0.70	0.87
CD14+CD16- Monocytes, donor3	11910-125G2	2214.31	9.59	2.45	0.67	1.34	0.45	0.00	0.00	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	1539.72	4.08	1.79	0.77	0.77	0.77	0.77	1.02	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	3131.21	13.83	5.49	3.07	1.76	1.54	1.98	3.07	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	1794.90	4.84	0.84	0.84	0.84	0.84	0.21	0.63	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	1475.46	2.03	0.00	4.06	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	1546.47	8.14	4.07	1.36	1.36	0.00	0.00	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	1551.33	5.18	0.00	1.04	1.04	0.00	1.04	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	1344.85	3.73	0.53	1.07	0.53	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	1682.72	7.50	1.07	3.22	2.68	0.00	0.54	0.54	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	1426.34	0.70	1.40	1.40	1.40	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	1666.75	3.92	3.14	0.78	0.78	0.78	0.78	1.57	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	1606.99	1.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	1157.24	9.04	3.29	0.82	0.82	1.64	0.00	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	1076.53	7.25	1.45	1.45	0.73	0.00	0.73	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	1296.90	8.58	1.01	0.50	0.00	0.00	0.50	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	251.32	0.81	0.81	0.40	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	199.35	0.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	1675.76	2.01	3.01	2.01	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	2571.40	7.30	0.56	3.37	0.56	0.56	1.12	0.00	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	4042.75	7.14	2.63	2.63	1.88	0.00	0.75	1.50	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	4911.03	8.34	3.16	2.48	1.35	0.68	0.23	0.45	0.90
CD4+ T Cells, donor1	11225-116C1	1902.40	2.50	1.79	0.71	0.71	0.00	0.36	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	2981.60	26.33	9.80	4.90	1.84	1.84	7.35	1.22	0.61
CD4+ T Cells, donor3	11382-118B5	2647.34	21.35	5.79	7.32	3.35	2.44	2.44	0.61	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	3298.93	25.78	6.64	3.57	3.06	2.30	2.55	0.77	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	6886.15	17.52	5.61	2.92	2.02	2.02	0.67	1.35	1.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	3924.70	14.09	3.45	4.02	2.01	1.15	2.30	0.57	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	1824.30	4.74	2.37	1.42	0.47	0.95	0.47	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	2876.71	3.51	2.11	0.70	0.70	1.40	0.70	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	2027.18	19.78	0.00	6.59	3.30	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	4078.80	40.46	10.84	5.35	6.21	2.89	2.75	2.31	1.73
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	7206.06	53.38	11.02	7.46	6.27	5.42	2.54	2.20	1.53
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	3766.25	32.89	9.83	7.74	5.64	3.22	3.55	1.61	1.29
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	2311.43	12.55	3.14	3.14	2.69	0.90	2.24	1.79	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	5112.25	21.31	6.99	5.59	1.05	2.80	1.75	2.10	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	2811.92	9.24	3.52	2.20	1.32	1.32	1.76	0.88	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	3852.11	24.88	7.17	2.53	3.79	0.84	1.26	0.00	3.79
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	7185.50	33.87	10.18	7.27	5.61	4.36	3.74	3.74	1.66
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	4576.21	43.44	6.68	4.34	4.34	2.34	3.01	3.01	3.01
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	2000.08	10.88	4.35	3.54	2.18	1.09	1.09	0.54	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	3136.38	11.25	1.07	0.54	1.61	0.00	0.54	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1882.89	12.55	5.38	1.79	0.00	3.59	3.59	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	5672.44	30.97	6.49	4.08	4.82	1.85	1.67	1.48	2.23
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	7739.09	29.89	6.72	7.15	3.25	3.47	2.60	3.25	1.73
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	5334.28	33.41	10.09	6.30	3.15	2.94	1.89	1.26	1.26
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	2054.27	6.07	0.00	2.53	1.01	1.01	1.01	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	3464.28	5.63	3.03	2.17	0.43	1.30	1.30	0.43	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	2375.19	8.72	3.49	1.74	3.49	0.44	0.44	0.44	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	3072.64	9.40	1.98	3.96	3.46	2.97	1.48	1.48	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	2540.61	4.62	0.92	0.92	0.92	0.00	0.00	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	2488.75	6.98	1.40	0.00	0.00	0.00	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	3179.14	15.78	3.32	1.66	1.66	0.83	0.55	0.00	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	3536.08	16.20	2.21	2.45	1.23	0.74	0.25	0.49	1.47
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	3021.49	3.08	1.54	0.00	3.08	0.00	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	3082.32	17.91	6.80	3.22	2.86	0.36	0.72	0.72	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	2904.33	5.54	2.77	4.15	1.38	1.38	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	1395.03	5.24	1.64	1.31	1.64	0.00	0.33	1.64	0.65
CD8+ T Cells, donor2	11307-117C2	2059.62	18.40	4.88	4.51	2.25	1.88	2.25	0.38	0.75
CD8+ T Cells, donor3	11383-118B6	1918.41	11.61	4.54	5.05	1.77	0.00	0.25	0.50	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	13783.68	107.58	22.02	16.97	8.49	2.98	5.96	1.38	4.13
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	13199.27	82.44	17.25	10.78	9.59	2.16	2.64	1.92	4.07
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	13194.77	123.39	26.54	16.14	10.12	4.92	11.22	5.75	5.47
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	17778.51	173.52	42.63	43.23	17.71	6.30	12.31	1.80	10.21
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	14013.79	119.75	19.92	17.76	9.36	3.36	8.16	2.88	4.56
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	14147.93	113.92	18.42	13.87	8.19	4.55	4.32	1.36	3.87
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	10939.39	79.74	13.04	12.17	4.35	1.96	4.56	1.52	3.91
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	11736.53	108.18	26.85	14.48	9.21	4.21	3.42	3.68	5.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	11689.66	129.92	19.93	14.07	8.44	4.69	4.22	2.81	5.63
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	8955.49	64.60	14.49	14.79	6.94	4.83	5.13	1.21	2.72
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	8231.15	67.98	15.98	11.33	3.78	3.20	5.52	3.78	4.07
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	7358.11	77.00	14.12	11.72	4.26	2.40	3.46	0.80	4.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	4722.02	33.71	10.94	4.38	2.19	0.88	0.88	0.44	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	4512.85	25.50	5.92	7.29	3.19	1.82	2.28	0.46	1.82
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	4932.45	22.38	8.95	2.98	0.75	0.00	1.49	0.00	4.48
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	14332.38	127.13	20.17	22.33	10.80	5.04	4.32	2.52	7.56
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	13430.26	84.30	26.18	11.80	8.34	4.60	4.89	1.44	2.01
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	12501.11	95.22	23.33	12.73	8.96	5.19	6.13	2.83	5.19
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	10644.17	144.51	20.28	18.06	7.61	2.85	8.24	2.22	7.29
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	10249.24	86.43	17.53	14.76	10.76	3.08	4.00	2.46	4.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	9920.77	102.91	22.12	12.50	8.34	4.17	4.49	1.92	4.49
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	7275.64	54.69	13.00	7.27	3.06	3.82	3.06	1.91	4.21
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	7048.56	52.81	7.49	9.06	4.34	1.97	2.36	1.58	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	7142.81	52.95	12.86	8.32	2.27	3.78	3.03	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	2972.54	18.47	1.61	2.41	4.01	1.61	0.80	1.61	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	2890.74	23.78	2.10	1.40	0.00	2.80	0.00	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	3182.56	27.05	5.01	5.01	3.01	1.00	0.00	2.00	5.01
Cardiac Myocyte, donor1	11525-119I4	5512.46	36.55	12.79	0.00	5.48	0.00	3.66	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	6288.28	36.56	9.39	5.43	1.98	2.47	3.46	1.48	0.99
Cardiac Myocyte, donor3	11686-122I3	5738.02	12.31	4.21	3.37	2.10	1.26	1.16	0.74	0.95
Chondrocyte - de diff, donor1	11261-116G1	4425.21	32.59	6.24	5.89	3.47	2.08	0.69	1.04	0.35
Chondrocyte - de diff, donor2	11338-117F6	7749.35	40.16	3.20	3.91	5.33	2.49	1.07	1.78	3.91
Chondrocyte - de diff, donor3	11410-118E6	4885.90	52.57	12.97	12.74	7.28	7.05	4.55	5.23	1.82
Chondrocyte - re diff, donor2	11339-117F7	4747.54	13.43	3.58	1.79	7.16	3.58	0.90	1.79	2.69
Chondrocyte - re diff, donor3	11411-118E7	2822.74	18.20	4.85	3.64	2.83	4.04	2.43	1.21	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	9330.65	44.87	13.31	11.82	9.30	4.02	5.74	4.36	2.07
Ciliary Epithelial Cells, donor2	11323-117D9	10859.93	114.79	36.77	18.38	10.90	10.69	5.34	6.63	5.34
Ciliary Epithelial Cells, donor3	11399-118D4	10479.29	70.53	27.08	20.62	11.86	6.90	5.93	5.31	2.04
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	2269.86	13.57	3.67	2.75	2.38	2.29	1.38	1.10	0.64
Corneal Epithelial Cells, donor1	11526-119I5	7629.27	13.17	1.98	3.95	4.83	1.54	0.88	0.88	1.76
Corneal Epithelial Cells, donor2	11606-120I4	6402.41	46.64	4.55	2.28	1.14	3.41	2.28	3.41	1.14
Corneal Epithelial Cells, donor3	11687-122I4	4871.30	35.53	6.90	6.65	5.37	3.07	3.32	1.53	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	3314.95	7.92	4.13	2.15	1.32	0.83	0.83	0.99	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	3009.32	9.15	5.05	2.52	2.21	1.58	0.95	1.26	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	2429.29	6.90	0.00	3.45	0.00	0.00	0.00	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	2889.16	28.08	7.99	7.67	5.51	2.59	2.48	1.84	1.40
Dendritic Cells - plasmacytoid, donor1	11228-116C4	1812.41	3.07	2.73	1.37	1.71	0.34	0.68	0.34	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	1962.53	3.92	0.00	0.00	1.96	0.00	1.31	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	1787.21	2.90	1.45	0.97	0.97	0.00	1.45	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	7336.00	20.18	10.51	6.34	5.34	1.83	1.83	0.33	1.83
Endothelial Cells - Aortic, donor1	11263-116G3	7790.04	26.40	9.39	6.45	1.17	2.35	2.35	1.17	2.35
Endothelial Cells - Aortic, donor2	11340-117F8	12562.42	29.41	5.66	6.22	2.83	1.41	2.26	1.70	1.41
Endothelial Cells - Aortic, donor3	11412-118E8	6285.44	22.80	9.83	1.97	9.04	3.54	1.57	0.39	1.18
Endothelial Cells - Artery, donor1	11264-116G4	8889.68	77.66	6.69	10.18	5.82	2.33	3.20	3.20	4.07
Endothelial Cells - Artery, donor2	11341-117F9	10651.98	168.22	39.53	31.53	12.47	9.41	8.47	5.88	2.82
Endothelial Cells - Artery, donor3	11413-118E9	10714.72	74.16	27.35	20.86	13.15	7.01	3.51	3.16	3.33
Endothelial Cells - Lymphatic, donor1	11236-116D3	4210.29	14.63	3.99	3.55	2.66	1.33	1.77	1.33	1.11
Endothelial Cells - Lymphatic, donor2	11317-117D3	3884.88	9.74	3.96	1.83	3.65	1.22	1.22	0.61	1.22
Endothelial Cells - Lymphatic, donor3	11393-118C7	4353.15	10.71	1.97	1.69	2.54	0.28	1.97	0.56	1.13
Endothelial Cells - Microvascular, donor1	11265-116G5	5658.32	47.24	4.75	7.13	2.67	4.75	3.27	2.97	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	7093.53	30.20	4.69	3.64	2.60	2.60	1.04	0.52	2.60
Endothelial Cells - Microvascular, donor3	11414-118F1	6948.40	64.94	16.73	22.26	6.66	6.52	7.51	5.81	1.84
Endothelial Cells - Thoracic, donor1	11266-116G6	8968.28	36.41	3.20	5.20	2.80	3.60	3.60	0.40	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	8169.01	143.09	23.06	8.39	7.86	6.81	7.86	2.10	3.14
Endothelial Cells - Umbilical vein, donor1	11243-116E1	5331.91	39.39	9.44	7.21	5.59	3.23	3.35	2.61	2.98
Endothelial Cells - Umbilical vein, donor2	11324-117E1	3973.94	20.42	5.65	2.17	3.26	1.74	1.09	0.22	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	6467.26	18.32	5.74	3.18	3.18	1.83	0.73	0.24	0.61
Endothelial Cells - Vein, donor1	11267-116G7	8108.16	35.26	7.96	7.96	2.28	3.41	0.00	3.41	2.28
Endothelial Cells - Vein, donor2	11344-117G3	12376.74	33.53	7.68	4.19	5.59	4.19	2.10	0.00	2.79
Endothelial Cells - Vein, donor3	11416-118F3	7004.87	40.66	15.39	18.68	10.05	5.34	3.30	3.14	1.73
Eosinophils, donor1	12244-129H3	4025.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1447.28	1.65	0.00	0.00	1.65	0.00	0.00	0.00	1.65
Eosinophils, donor3	12246-129H5	1141.38	7.13	3.57	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	8614.21	11.73	2.93	2.93	2.20	1.95	0.24	0.24	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	5585.24	41.60	12.48	4.16	6.24	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	20352.23	146.42	0.00	0.00	0.00	32.54	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	5275.11	29.56	8.62	9.03	7.39	2.05	1.64	1.64	2.87
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	5769.05	118.90	35.26	50.80	34.60	25.95	15.77	16.75	5.58
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	5067.07	80.28	17.77	28.28	9.32	14.52	7.26	8.56	3.03
Fibroblast - Aortic Adventitial, donor1	11245-116E3	5765.41	62.22	14.19	14.07	9.34	12.73	4.37	5.58	2.30
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	6313.03	14.19	8.19	5.32	6.82	1.77	1.50	1.23	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	7804.28	93.66	28.37	13.39	12.87	11.07	2.85	2.95	1.37
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	3344.48	38.21	2.90	5.80	3.16	3.69	0.79	2.11	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	4819.89	57.14	13.29	15.28	8.30	10.63	1.66	5.32	1.33
Fibroblast - Cardiac, donor1	11268-116G8	7987.47	78.48	24.04	30.85	13.61	8.17	5.90	4.99	2.72
Fibroblast - Cardiac, donor2	11345-117G4	10865.19	38.66	15.92	4.55	9.10	3.03	5.31	0.76	4.55
Fibroblast - Cardiac, donor3	11417-118F4	7956.78	88.64	21.29	22.87	11.36	6.94	8.99	6.31	2.37
Fibroblast - Cardiac, donor4	11452-119A3	5368.95	7.58	2.73	1.52	1.82	0.30	0.61	0.30	0.61
Fibroblast - Cardiac, donor5	11456-119A7	3755.22	42.64	7.87	12.69	6.47	3.81	3.68	1.27	1.40
Fibroblast - Cardiac, donor6	11460-119B2	5307.15	46.24	10.61	12.58	4.85	3.64	3.79	0.91	2.43
Fibroblast - Choroid Plexus, donor1	11492-119E7	9195.50	21.44	4.82	3.48	3.08	2.68	0.94	0.27	1.07
Fibroblast - Choroid Plexus, donor2	11572-120E6	7086.21	46.16	7.77	5.18	2.59	1.73	1.29	0.86	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	8533.88	120.11	2.93	8.79	8.79	5.86	4.39	5.86	8.79
Fibroblast - Conjunctival, donor1	11531-120A1	3826.76	4.61	1.15	0.46	2.08	0.23	0.46	0.23	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	7083.70	33.07	6.78	3.56	2.37	4.92	3.05	2.88	1.53
Fibroblast - Dermal, donor1	11269-116G9	3903.24	31.70	3.76	11.50	5.17	2.82	2.11	1.41	0.94
Fibroblast - Dermal, donor2	11346-117G5	5813.44	10.38	2.36	1.89	1.89	0.94	1.89	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	5030.19	40.38	10.28	12.09	6.04	6.41	2.66	3.51	1.09
Fibroblast - Dermal, donor4	11450-119A1	3965.86	44.09	7.69	12.55	3.96	3.62	2.94	1.58	2.26
Fibroblast - Dermal, donor5	11454-119A5	3928.86	33.67	7.85	10.47	4.36	3.14	3.31	0.87	0.87
Fibroblast - Dermal, donor6	11458-119A9	4710.77	55.55	7.96	12.51	7.47	4.06	3.09	0.97	2.92
Fibroblast - Gingival, donor1	11237-116D4	2982.06	9.16	3.96	4.16	1.25	1.04	1.67	0.21	1.04
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	9945.77	95.37	12.58	15.20	13.62	6.03	3.41	2.36	2.62
Fibroblast - Gingival, donor2	11318-117D4	4503.98	72.35	18.58	11.86	6.19	4.09	5.93	3.03	2.77
Fibroblast - Gingival, donor3	11394-118C8	2900.31	19.43	7.35	3.58	2.61	1.55	1.35	1.16	1.64
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	4946.17	47.79	8.31	9.35	8.31	7.27	1.04	2.08	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	4493.72	91.45	18.68	7.75	10.40	7.40	2.64	2.82	2.64
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	11213.63	53.16	9.20	8.11	8.57	4.21	3.59	1.56	2.18
Fibroblast - Gingival, donor6 (control)	11922-125H5	9953.28	54.63	12.44	12.31	7.98	4.19	4.73	3.65	2.84
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	8530.86	26.11	5.65	4.23	4.94	4.23	2.12	2.82	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	10813.17	52.79	10.53	9.21	9.36	4.09	2.78	3.66	2.34
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	10343.08	64.63	11.04	5.18	6.27	5.18	2.45	3.14	3.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	14702.83	99.82	16.12	8.56	11.63	4.72	5.37	3.62	4.50
Fibroblast - Gingival, donor9 (control)	11927-125I1	7285.73	71.46	8.07	12.03	12.77	7.48	3.52	4.55	1.47
Fibroblast - Lung, donor1	11270-116H1	8461.95	32.62	17.67	13.59	5.44	1.36	1.36	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	3460.30	8.95	1.49	0.00	2.98	0.00	0.00	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	5631.28	53.81	16.67	15.83	6.75	4.43	5.28	5.28	2.32
Fibroblast - Lymphatic, donor1	11506-119G3	13814.83	14.99	5.83	5.00	5.83	1.67	0.83	0.00	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	4844.84	26.57	5.59	2.80	9.79	0.00	2.80	0.00	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	4973.95	34.14	7.00	3.64	2.80	1.96	1.40	1.68	1.40
Fibroblast - Mammary, donor1	11540-120B1	14401.75	18.67	3.65	2.84	4.47	0.81	0.41	1.22	0.81
Fibroblast - Mammary, donor2	11620-122A9	8168.16	59.91	11.98	3.99	0.00	3.99	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	8559.15	11.91	0.00	5.96	17.87	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	6480.08	10.67	5.04	2.72	1.94	1.75	1.16	0.58	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	4229.34	53.09	16.53	8.65	6.37	3.19	2.28	2.12	1.97
Fibroblast - Periodontal Ligament, donor3	11395-118C9	4105.43	6.12	1.53	2.14	3.06	1.22	0.31	0.61	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	10280.17	62.20	14.50	10.69	3.82	2.67	2.67	0.38	4.96
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	11175.70	157.67	40.77	22.14	18.90	14.31	9.99	7.29	6.21
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	5676.12	55.20	14.15	11.48	9.97	5.68	1.97	1.04	2.20
Fibroblast - Pulmonary Artery, donor1	11250-116E8	7684.00	25.31	10.50	11.83	5.53	3.76	5.86	3.54	1.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	13378.07	21.34	7.52	3.25	4.06	3.45	3.05	2.03	2.44
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	8574.38	55.46	10.69	4.01	6.01	1.34	3.34	2.67	4.01
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	7340.67	29.26	11.47	10.28	5.14	2.37	4.35	1.98	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	9834.87	71.64	11.71	10.72	4.56	2.98	2.78	2.18	2.78
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	5141.87	22.56	4.44	4.80	4.80	2.31	0.89	0.71	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	6519.38	23.06	6.11	1.97	5.72	2.17	1.18	1.58	1.77
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	7602.30	43.62	7.52	9.33	3.61	1.20	3.01	3.61	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	6380.69	47.71	7.12	6.05	3.78	2.70	2.70	0.32	1.51
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	12696.75	59.73	7.85	9.62	5.57	3.04	2.78	1.27	2.53
Fibroblast - skin normal, donor1	11553-120C5	12101.08	36.26	7.22	4.10	3.94	2.95	1.15	0.98	1.15
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	9333.41	14.84	10.83	4.61	5.21	1.80	2.21	2.01	0.80
Fibroblast - skin normal, donor2	11561-120D4	12928.38	87.20	15.77	15.27	8.24	4.22	4.12	1.51	3.52
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	12690.65	63.47	10.88	8.76	5.74	2.42	3.93	3.32	2.42
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	7435.93	26.68	5.80	3.23	4.89	1.49	1.33	0.75	1.24
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	3105.49	36.93	6.33	3.76	4.27	2.39	1.37	0.51	1.20
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	7682.35	41.71	5.58	7.88	5.91	3.28	1.64	0.99	1.31
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	8214.85	64.02	12.89	11.61	8.52	4.05	3.52	1.70	2.24
Fibroblast - skin walker warburg, donor1	11554-120C6	9277.45	28.68	7.93	5.90	3.04	2.36	2.36	1.01	1.35
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	9110.13	129.69	34.03	37.32	15.21	12.23	28.23	10.82	6.59
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	3656.37	199.44	66.48	0.00	44.32	0.00	44.32	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	1934.80	44.45	10.46	1.74	5.23	0.00	0.00	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	4975.71	15.78	4.68	3.47	3.64	5.20	1.04	1.39	0.87
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	8447.94	27.85	7.55	5.47	8.07	3.12	3.12	0.78	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	4981.22	27.85	4.09	3.32	6.39	1.79	1.02	0.77	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	7632.55	84.21	16.84	10.72	12.25	9.19	3.06	8.42	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	8556.54	104.01	20.42	17.23	15.31	14.04	5.74	4.47	3.19
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	5364.10	56.20	15.97	9.41	5.13	7.99	5.13	3.99	2.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	4168.35	125.47	16.27	17.65	14.89	26.75	3.31	8.27	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	3411.65	64.84	12.33	10.50	15.98	16.44	2.28	12.33	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	4485.07	59.84	11.69	11.89	9.11	10.30	2.77	6.14	3.37
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	3711.53	119.22	17.18	13.22	14.54	18.50	2.91	10.04	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	2905.32	63.92	9.13	8.15	17.61	12.72	1.96	6.85	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	4865.34	38.47	9.29	2.65	6.63	5.75	2.65	3.10	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	4600.32	66.85	7.91	8.62	3.67	2.54	5.51	2.26	2.97
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	4524.00	61.20	12.44	12.68	5.42	3.57	5.54	3.08	2.46
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	5103.88	53.19	15.58	9.67	5.91	5.10	4.30	3.49	2.15
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	7332.14	86.48	20.07	17.22	9.29	5.82	9.17	3.47	1.86
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	8807.79	123.48	12.18	14.12	8.72	5.12	9.41	5.95	4.43
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	7379.28	113.24	27.85	25.21	9.56	7.32	6.71	10.57	3.05
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	5772.69	46.32	11.87	9.81	6.62	7.53	2.51	2.05	2.05
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	5102.09	77.48	11.58	14.70	6.23	6.23	5.73	5.98	3.36
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	6504.62	52.02	12.68	9.84	8.09	3.06	3.06	2.84	1.31
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	5628.89	70.62	15.07	16.84	6.80	5.91	4.14	2.95	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	4757.30	70.26	7.63	9.06	3.97	2.23	5.40	3.50	1.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	4620.10	32.84	8.49	9.38	4.02	3.35	2.90	2.90	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	6146.60	83.07	18.95	15.32	9.07	10.89	6.86	7.26	2.82
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	4885.18	72.10	8.31	9.67	5.26	4.92	6.62	3.22	3.56
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	5043.32	24.12	8.07	3.19	5.76	3.37	1.06	1.68	1.15
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	6660.53	22.06	14.05	4.37	8.53	4.37	1.35	1.46	1.14
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	7289.24	24.42	9.39	3.76	7.17	2.39	0.51	2.90	1.37
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	5158.35	52.23	8.74	12.28	6.31	3.43	4.98	3.65	2.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	4448.50	19.30	5.99	2.91	4.24	2.50	1.25	1.41	0.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	4855.42	13.68	5.31	3.88	2.25	2.25	0.61	1.63	2.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	6482.95	82.93	14.44	17.74	7.01	9.70	6.60	3.71	2.89
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	5337.62	55.11	8.30	6.57	5.30	3.92	4.73	2.65	1.73
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	5202.89	51.53	8.17	11.51	8.51	5.34	3.17	2.33	2.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	6124.67	60.18	13.67	13.67	5.73	7.94	2.42	3.53	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	5448.30	90.15	15.99	16.73	7.38	4.92	9.47	6.52	4.06
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	5223.28	46.84	9.56	12.81	4.86	5.19	3.08	3.40	1.62
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	6189.79	76.97	14.43	14.11	5.13	5.13	5.45	5.45	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	4927.32	55.43	9.19	10.14	4.83	3.79	6.16	4.07	1.61
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	5214.28	34.32	9.02	7.43	5.69	4.43	3.48	4.90	1.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	5787.39	84.23	15.81	18.55	6.99	5.78	3.34	4.26	3.65
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	4444.24	56.87	11.29	12.13	5.23	3.76	5.85	3.35	2.20
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	5443.65	41.28	8.78	10.76	5.49	6.15	2.63	5.05	1.98
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	5196.60	47.69	10.66	11.50	5.89	6.73	3.09	3.93	2.24
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	5012.10	57.40	13.43	5.09	5.56	1.76	3.80	1.57	1.76
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	5608.52	49.47	9.09	12.57	4.01	5.88	3.74	4.55	1.87
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	5362.52	35.50	9.95	6.58	3.21	3.83	2.45	1.68	2.30
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	4583.40	49.87	9.33	8.29	5.31	3.11	4.92	2.85	1.81
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	5744.58	34.97	7.59	11.39	5.69	5.96	4.88	4.07	2.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	6921.65	71.90	15.30	13.46	5.35	5.35	7.93	3.13	2.21
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	7020.86	64.92	16.67	15.79	7.24	4.61	4.61	3.73	2.19
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	6345.19	26.78	5.95	1.98	3.97	1.98	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	6926.71	54.08	13.59	17.41	5.41	5.14	5.01	3.17	1.85
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	6894.65	63.15	19.37	17.75	8.47	6.86	6.25	2.82	4.44
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	5322.62	3.81	5.59	3.05	3.81	1.02	1.02	0.76	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	4448.00	36.63	5.77	7.17	5.57	2.59	2.59	1.39	1.39
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	4559.12	64.56	9.55	12.48	5.08	3.70	7.86	6.01	1.69
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	4873.98	51.55	5.11	4.71	3.27	1.23	2.86	2.25	3.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	5262.86	15.33	10.33	9.07	4.38	2.82	3.13	3.13	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	5062.27	14.98	4.24	7.35	4.52	3.67	1.98	3.67	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	4680.77	33.67	4.15	5.07	5.07	1.38	1.84	2.77	3.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	5211.93	59.40	22.27	9.90	12.37	9.90	0.00	9.90	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	5008.40	75.43	13.54	13.15	5.80	3.48	2.32	6.19	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	4253.44	73.81	8.02	4.81	3.21	4.81	3.21	6.42	4.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	4480.96	52.16	8.69	13.91	12.17	6.96	1.74	5.22	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	4077.93	45.57	11.39	11.07	6.18	6.18	4.23	4.23	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	4275.33	65.06	4.94	13.59	6.18	5.77	2.88	1.65	2.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	4635.18	83.31	6.66	19.99	16.66	6.66	6.66	3.33	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	3695.54	44.46	5.59	7.55	4.75	4.47	2.52	4.75	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	4269.23	40.86	5.23	7.52	3.92	2.61	2.61	5.56	2.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	3703.46	38.59	6.71	7.55	6.71	5.87	0.84	4.19	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	3924.69	43.89	6.04	10.18	3.50	4.45	1.59	3.82	1.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	4083.42	44.84	5.77	9.85	2.38	4.42	3.40	3.06	2.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	3184.42	33.41	2.09	6.26	2.09	2.09	0.00	0.00	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	4188.15	50.40	7.45	13.17	3.44	5.73	1.72	4.58	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	4190.53	39.37	5.33	7.10	3.26	3.55	2.07	3.55	2.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	3347.63	32.19	8.47	6.78	1.69	6.78	6.78	3.39	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	3746.92	62.13	9.11	11.60	4.56	6.21	5.80	3.73	4.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	3807.71	39.35	6.90	9.90	3.45	3.45	3.45	2.53	2.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	3740.63	42.15	26.34	5.27	0.00	0.00	0.00	5.27	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	3266.35	36.90	4.23	2.31	3.08	1.92	1.54	2.69	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	3542.97	38.14	4.24	8.80	4.56	2.93	2.28	3.91	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	3025.83	38.79	8.03	9.36	3.34	5.35	2.68	5.35	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	4341.97	67.42	11.56	9.63	3.47	3.47	2.31	5.39	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	5866.68	60.59	8.22	12.32	3.77	5.82	1.71	4.79	3.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	3754.51	47.21	9.94	14.91	7.45	7.45	0.00	4.97	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	4408.03	50.96	5.66	9.44	6.61	9.44	6.13	1.42	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	4085.65	56.12	10.86	9.66	6.64	6.64	3.02	4.22	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	4368.51	64.09	10.17	12.21	5.60	6.61	1.53	0.51	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	4308.26	66.61	9.17	17.15	4.79	7.98	4.79	5.98	3.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	4395.80	53.78	6.91	8.88	2.96	4.93	2.96	2.47	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	3254.48	31.87	12.98	22.43	4.72	7.08	3.54	2.36	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	4375.26	48.43	5.83	11.67	4.08	7.00	4.08	3.50	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	4174.65	57.93	3.95	10.53	5.27	3.51	1.76	0.44	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	3009.31	25.43	9.32	14.41	3.39	5.93	2.54	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	2628.21	13.73	1.79	4.78	3.58	4.18	0.60	2.39	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	3147.80	46.10	3.88	13.59	1.94	6.31	1.46	0.97	2.43
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	8809.72	75.33	13.70	12.55	4.57	4.57	0.00	2.28	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	8508.43	143.04	32.43	34.10	11.23	10.40	11.23	12.06	4.16
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	15460.11	56.22	32.61	19.12	13.49	9.00	4.50	4.50	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	6373.99	62.80	12.37	7.93	4.44	3.17	3.49	2.22	2.54
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	5064.29	43.45	9.61	8.77	3.76	6.27	2.92	2.09	2.51
Hep-2 cells mock treated, biol_rep1	11898-125E8	6831.51	65.45	15.55	14.51	5.92	4.41	8.36	3.25	3.37
Hep-2 cells mock treated, biol_rep2	11899-125E9	7753.73	72.25	14.35	10.63	8.44	4.39	5.91	4.22	2.19
Hep-2 cells mock treated, biol_rep3	11900-125F1	7639.56	59.38	11.83	9.56	5.69	4.32	5.01	1.82	1.59
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	7378.46	85.04	20.22	15.85	10.17	5.36	11.48	4.81	3.50
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	8060.49	65.98	15.04	10.32	7.09	2.58	5.59	3.01	2.79
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	7624.00	46.72	10.76	6.24	7.53	1.94	6.24	1.72	1.94
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	5509.29	47.08	13.95	9.09	5.11	2.86	6.35	1.49	1.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	5758.75	37.05	7.55	4.97	4.29	2.23	3.95	1.37	2.40
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	6590.06	58.95	9.93	9.61	4.81	3.52	3.52	1.92	3.52
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	6390.33	53.16	8.39	19.59	6.16	3.36	1.68	1.12	2.24
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	11717.46	76.17	10.82	8.22	6.92	5.19	3.46	3.90	2.16
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	3643.16	103.11	5.29	2.64	5.29	0.00	0.00	2.64	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	9271.64	15.17	5.29	6.35	2.47	1.41	2.47	1.76	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	14979.95	59.57	10.17	5.09	5.81	2.18	5.09	2.91	2.91
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	4847.41	47.73	8.04	10.32	4.55	2.80	5.59	2.27	2.27
Hepatocyte, donor1	11523-119I2	250.59	4.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	3379.61	29.09	3.23	1.08	0.00	2.15	2.15	1.08	1.08
Hepatocyte, donor3	11684-122I1	815.39	5.52	1.23	0.61	0.00	0.61	0.61	1.23	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	3637.42	36.55	10.44	7.18	2.61	2.61	0.65	1.31	3.26
Intestinal epithelial cells (polarized), donor1	11246-116E4	1422.37	11.54	2.27	1.92	1.22	0.87	1.05	0.87	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	7174.81	17.56	6.17	4.12	3.84	2.06	2.74	1.10	0.82
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	2623.52	3.18	6.37	3.18	3.18	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	2736.88	13.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	1841.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	2356.21	23.53	5.54	5.54	1.38	0.00	1.38	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	3103.30	25.03	7.51	5.01	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	2136.29	35.60	0.00	0.00	0.00	0.00	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	2657.74	33.32	7.69	0.00	0.00	2.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	3295.52	27.42	9.14	0.00	9.14	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	2166.85	34.11	6.50	1.62	1.62	0.00	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	2220.85	26.68	8.34	8.34	6.67	3.33	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	2853.62	32.68	3.63	10.89	0.00	0.00	7.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	2064.61	33.09	2.65	2.65	1.32	0.00	1.32	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	2343.68	35.48	5.54	3.33	0.00	0.00	3.33	0.00	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	3137.73	20.95	0.00	0.00	0.00	0.00	0.00	10.48	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	1604.26	23.30	6.30	1.26	1.26	0.00	2.52	0.63	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	2304.47	20.11	7.73	0.00	0.00	0.00	1.55	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	2019.59	14.63	0.00	0.00	14.63	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	1763.04	20.67	6.46	6.46	1.94	1.29	2.58	1.94	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	2509.87	25.76	4.83	4.83	1.61	0.00	0.00	1.61	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	2509.12	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	1787.84	24.45	6.52	4.07	0.81	0.81	2.44	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	2560.00	13.43	6.72	1.26	0.84	2.10	0.84	0.84	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	2227.73	43.12	0.00	0.00	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	1686.13	23.31	1.61	4.02	0.80	0.80	4.02	0.80	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	2280.50	13.85	3.69	3.69	0.92	0.00	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	1764.45	30.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	1545.45	26.43	3.78	1.89	0.94	0.47	2.36	0.94	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	1943.66	33.56	8.16	4.53	0.91	3.63	1.81	1.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	2196.63	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	1807.88	20.45	2.15	2.15	2.15	0.00	4.30	3.23	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	2706.09	24.14	5.08	1.27	1.27	1.27	1.27	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	2415.26	32.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	1961.50	35.71	3.83	1.91	1.28	0.00	0.64	0.64	2.55
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	2466.06	20.05	7.29	5.47	0.00	0.00	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	2370.65	0.00	0.00	0.00	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	1856.57	31.42	8.57	5.00	0.00	1.43	0.71	0.00	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	2339.41	16.59	3.32	3.32	0.00	3.32	3.32	0.00	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	1751.28	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	1785.29	23.46	4.01	4.63	1.54	0.93	2.47	1.23	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	2163.42	19.32	0.00	1.76	0.00	0.00	0.00	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	2923.11	9.43	3.14	9.43	0.00	3.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	1947.78	31.29	2.78	2.78	1.39	0.00	2.09	0.00	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	2104.65	8.85	6.64	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	1783.11	16.21	9.73	3.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	1545.06	26.16	4.36	5.23	0.00	0.00	1.74	1.74	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2198.04	24.75	9.00	4.50	4.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	2080.29	13.94	0.00	0.00	0.00	0.00	0.00	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	1761.24	24.54	7.47	2.13	1.07	1.07	1.07	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2043.53	15.24	2.77	2.77	1.39	1.39	2.77	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	1932.03	14.25	0.00	2.85	0.00	0.00	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	1324.49	24.85	7.36	4.60	1.84	0.92	2.76	2.76	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	2520.09	33.28	12.10	6.05	0.00	0.00	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	2446.22	18.63	18.63	6.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	1789.07	19.03	2.11	2.11	0.00	0.00	6.34	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	6000.48	37.29	8.89	3.10	4.73	3.67	1.71	1.96	1.31
Keratinocyte - epidermal, donor2	11349-117G8	5209.22	3.51	3.51	1.17	3.51	0.59	1.17	0.59	0.59
Keratinocyte - epidermal, donor3	11421-118F8	4410.12	36.54	10.89	11.74	4.54	2.93	5.21	3.12	1.61
Keratinocyte - oral, donor1	11251-116E9	4620.84	29.29	8.51	5.68	3.18	1.70	2.84	1.36	1.02
Keratocytes, donor1	11527-119I6	3183.19	4.81	1.72	1.03	1.03	0.34	0.69	0.00	0.34
Keratocytes, donor2	11607-120I5	6702.70	26.95	2.34	1.17	3.52	1.17	0.00	1.17	2.34
Keratocytes, donor3	11688-122I5	2085.44	14.03	2.57	3.36	2.77	1.19	0.20	1.58	1.19
Krukenberg tumor cell line:HSKTC	10687-109F3	1237.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	7488.64	62.57	10.79	15.10	5.39	4.31	2.16	7.55	1.08
Lens Epithelial Cells, donor2	11609-120I7	6679.68	11.76	3.58	3.34	2.42	2.08	1.73	1.04	1.04
Lens Epithelial Cells, donor3	11690-122I7	11753.74	15.54	6.05	2.32	4.24	2.02	1.11	1.31	0.81
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	9522.80	40.32	12.09	5.45	6.64	3.08	3.44	3.56	2.37
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	3880.25	22.61	7.54	5.02	5.30	3.91	2.23	1.40	1.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	3972.92	49.43	11.49	5.82	5.51	5.04	4.25	2.20	1.73
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	7545.76	44.09	8.07	3.23	3.76	1.08	1.08	1.08	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	4366.31	25.21	7.88	5.04	3.47	3.15	1.89	1.89	2.52
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	4100.29	55.42	13.37	8.63	5.07	4.85	5.39	3.88	2.59
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	7443.28	32.83	5.75	6.57	2.46	2.87	2.46	2.46	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	4727.22	34.38	5.06	4.55	3.29	2.53	2.02	2.78	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	4369.88	54.05	12.53	7.88	5.77	5.07	4.08	2.67	2.53
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	6767.17	36.78	5.93	2.37	4.35	2.77	2.77	1.98	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	3833.08	22.49	6.79	4.65	4.46	2.91	2.52	2.13	1.36
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	4503.55	37.03	9.26	6.85	6.11	4.26	3.52	0.74	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	7595.29	38.33	7.32	6.27	3.83	2.09	3.83	1.74	1.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	4339.46	25.04	5.96	4.77	3.10	2.39	2.15	2.39	1.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	4326.19	37.63	9.34	6.87	7.28	3.02	4.12	3.43	0.96
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	6866.24	36.34	8.31	6.16	4.93	2.46	2.46	3.08	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4494.41	29.30	8.11	5.30	5.92	4.36	3.12	1.25	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	5035.54	42.82	5.86	4.39	6.04	4.57	4.94	1.28	2.38
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	7623.85	28.30	8.56	6.91	5.27	1.97	2.30	0.66	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4319.57	37.49	10.25	3.22	3.22	4.39	2.05	1.46	1.76
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	5017.16	62.73	14.44	6.22	4.98	3.49	5.23	3.98	3.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	7347.68	36.86	8.24	4.85	2.42	1.45	0.97	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	3836.13	29.35	7.00	5.66	3.77	2.96	3.23	1.35	1.89
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	4167.13	68.73	9.99	6.51	6.66	4.39	5.90	3.33	2.57
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	7794.85	37.33	2.59	7.26	3.11	2.07	2.07	0.00	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	3746.63	20.52	5.23	3.77	3.56	2.72	3.14	1.68	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	4142.30	46.46	9.17	6.92	5.56	3.91	3.76	4.36	2.26
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	7719.34	39.90	11.01	7.57	2.06	3.44	2.06	2.06	4.13
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	3815.84	21.83	9.78	5.46	3.95	2.63	2.63	1.13	1.88
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	4327.93	65.10	14.00	10.50	5.94	4.24	5.94	4.56	2.44
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	7060.78	25.20	5.81	3.88	0.97	1.94	1.94	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	3716.41	20.18	7.94	3.31	2.98	2.65	2.65	1.98	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	4450.69	53.03	10.53	11.27	5.20	4.21	7.19	3.72	1.36
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	7117.29	41.09	5.55	4.07	2.22	3.33	2.22	0.37	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	3687.46	15.57	5.44	3.71	3.46	1.98	0.99	0.74	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	4328.02	49.64	14.02	6.32	7.01	3.99	5.09	2.34	2.06
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	7053.85	31.52	7.08	5.15	5.47	1.61	1.93	0.96	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	3760.90	25.56	6.09	3.96	4.26	4.56	0.91	3.04	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	3909.95	33.17	7.70	6.44	3.50	3.78	3.64	3.36	1.68
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	6967.23	27.73	9.60	7.11	4.62	3.56	1.78	0.71	1.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	3687.21	27.63	7.27	5.33	4.85	3.39	1.45	1.94	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	4688.77	42.17	13.07	8.25	5.76	5.29	4.05	4.05	2.02
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	6819.76	28.65	6.80	4.30	3.58	2.51	3.22	1.79	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	3813.60	16.33	3.27	1.96	3.27	1.31	2.94	0.98	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4146.75	37.90	10.83	6.36	7.06	3.77	3.06	1.18	2.83
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	8949.60	34.90	8.17	5.07	7.55	2.97	3.47	3.71	1.86
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	3802.98	15.88	3.07	3.33	3.84	3.33	1.02	2.05	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	4534.73	41.47	10.44	10.14	2.98	3.88	5.37	4.48	1.49
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	5306.99	20.39	2.27	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	5605.44	54.47	19.18	22.25	10.74	4.60	3.07	0.77	3.07
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	5949.70	35.63	8.16	10.39	4.45	2.97	2.97	2.97	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	6176.41	105.78	30.04	20.73	10.16	8.04	3.81	8.04	3.39
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	6012.71	90.03	14.77	19.69	7.74	5.63	4.92	7.03	4.92
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	7146.70	53.24	13.08	15.88	8.41	3.74	1.87	1.87	3.74
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	5438.15	144.28	30.40	18.55	13.91	5.15	6.18	5.67	9.79
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	5942.54	98.73	20.22	13.08	7.14	9.52	3.57	8.33	3.57
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	6129.37	30.54	8.82	9.95	5.88	3.39	4.07	4.30	2.26
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	5484.43	109.93	26.76	13.96	9.60	6.11	3.49	6.69	5.53
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	6120.57	86.43	16.66	23.86	6.75	6.30	7.20	3.15	2.70
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	7819.30	48.10	16.12	9.48	7.18	4.20	3.12	3.66	2.98
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	6043.66	96.03	24.14	15.92	11.81	6.68	5.14	5.14	3.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	5776.94	64.93	16.23	20.11	9.53	4.59	2.82	4.59	2.47
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	6221.29	54.64	11.33	10.66	2.67	4.00	2.00	3.33	4.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	5909.39	96.78	23.94	11.21	11.72	6.11	6.11	6.62	3.57
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	5835.04	73.10	19.48	19.21	7.74	4.27	5.87	3.47	1.87
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	6017.89	106.94	20.78	16.63	6.80	4.91	4.53	5.48	4.35
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	5720.25	105.53	19.02	23.93	9.82	11.04	7.98	3.07	3.07
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	7243.40	128.84	24.46	31.80	8.15	10.60	8.15	6.52	4.89
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	5802.07	92.25	27.70	21.66	10.20	7.91	5.83	3.12	3.96
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	5478.82	80.43	21.02	22.70	8.69	4.20	4.76	8.41	5.32
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	6382.96	68.00	11.33	26.79	5.15	5.15	6.18	4.12	5.15
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	5991.00	106.54	28.45	27.87	11.90	9.29	6.97	5.81	2.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	5251.30	75.33	22.12	16.44	8.97	5.68	3.89	3.89	4.48
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	5555.25	73.03	16.04	22.68	6.64	6.64	1.66	1.66	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	6971.83	131.14	38.53	20.86	11.67	7.42	5.30	7.42	5.66
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	5924.08	91.83	18.81	18.44	8.11	5.90	8.85	4.06	4.79
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	6161.62	82.89	19.57	19.57	5.76	5.76	9.21	2.30	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	7050.31	96.32	24.94	15.73	13.05	8.06	7.68	4.99	8.06
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	5835.11	155.12	36.23	22.08	14.15	11.89	5.66	9.62	9.06
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	6616.26	69.74	18.05	17.23	11.49	1.64	5.74	4.10	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	6684.26	126.08	28.92	27.56	14.46	5.87	9.04	5.42	5.42
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	6653.60	119.93	42.37	24.42	10.77	10.77	6.46	9.34	3.59
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	7317.42	89.63	14.19	20.17	7.47	0.75	6.72	7.47	6.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	6705.03	179.11	36.42	25.27	14.86	9.66	3.72	11.52	6.69
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	6435.36	88.30	21.11	18.95	11.20	7.32	4.31	4.74	2.58
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	7388.14	106.18	23.98	21.41	7.71	5.14	6.85	1.71	6.85
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	7624.42	162.26	26.65	22.66	11.33	6.00	8.66	6.66	7.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	6659.92	87.48	15.08	25.94	7.24	3.02	6.64	4.83	4.22
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	6647.83	73.94	22.04	22.04	7.11	6.40	10.66	3.55	4.98
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	6969.56	125.46	27.15	24.75	12.72	7.56	5.84	4.47	8.25
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	6599.85	91.78	32.20	19.32	5.37	4.83	5.37	5.37	3.76
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	7203.61	107.06	20.87	30.30	10.10	6.73	6.73	7.41	4.71
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	7552.62	137.42	34.08	23.71	18.89	9.63	9.26	9.26	6.67
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	5748.36	24.42	12.79	9.30	12.79	2.33	3.49	0.00	5.81
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	6734.65	68.75	15.87	17.98	6.35	11.64	6.35	4.23	5.29
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	7139.49	127.25	26.01	28.81	7.20	8.40	6.00	11.20	4.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	6051.22	63.24	16.72	15.26	9.45	5.09	2.91	5.09	3.63
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	6894.05	72.05	21.46	18.40	16.10	3.07	5.37	5.37	3.07
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	6980.37	128.75	24.66	18.74	10.85	7.40	7.40	9.37	5.43
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	5948.57	87.51	16.94	13.17	6.59	2.82	3.76	4.70	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	7365.83	90.00	23.63	23.63	11.56	8.55	7.04	7.04	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	6891.39	117.16	30.64	22.08	12.17	4.51	4.96	4.96	3.60
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	6695.09	118.76	20.65	17.21	5.16	3.44	6.88	0.00	5.16
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	7482.65	118.46	23.60	21.38	8.91	6.23	7.57	8.46	4.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	7377.09	123.17	28.94	27.76	11.34	7.04	3.52	7.04	8.99
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	6323.56	99.62	25.73	12.53	7.26	11.88	2.64	5.28	5.94
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	7614.20	95.48	23.35	24.39	11.42	7.26	10.38	5.71	3.63
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	6777.91	180.71	40.26	20.13	12.69	10.94	10.50	7.44	9.63
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	6753.94	101.76	27.40	22.92	15.65	6.71	6.15	8.95	5.03
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	7802.04	91.86	25.17	19.43	10.16	4.42	8.83	5.74	2.65
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	7773.32	124.59	24.69	20.06	8.10	7.71	9.26	7.33	4.63
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	7359.86	115.45	26.84	23.80	15.70	11.65	6.08	7.60	9.11
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	7826.42	87.95	22.11	15.38	9.13	7.69	7.69	4.81	6.73
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	7758.52	132.38	24.65	24.65	7.16	3.98	8.75	8.35	5.96
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	7589.80	126.99	29.17	24.91	11.54	10.33	4.25	6.68	6.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	7995.38	122.43	15.91	27.67	11.76	9.68	11.07	8.99	2.77
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	8095.33	143.64	34.58	22.04	17.10	13.30	6.84	6.46	13.30
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	7434.86	138.40	26.85	27.89	11.88	8.26	5.16	16.01	6.71
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	8681.03	126.98	19.95	31.44	8.47	11.49	6.05	4.84	6.05
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	7393.93	137.22	37.08	24.08	15.21	11.09	7.61	7.61	4.44
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	7538.95	78.90	20.79	12.79	7.46	8.00	8.00	4.80	3.20
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	8793.04	114.93	13.79	32.18	11.49	10.92	4.60	3.45	4.02
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	8180.95	145.01	38.05	27.77	13.37	11.31	9.26	10.28	3.09
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	8315.65	140.76	31.83	23.34	19.10	6.37	4.24	7.07	4.95
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	9276.14	141.87	15.89	24.97	10.21	7.38	8.51	5.67	7.94
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	8310.51	139.78	32.87	28.29	13.31	8.32	6.66	9.98	8.32
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	9113.82	196.54	45.42	40.72	11.75	14.88	8.61	12.53	11.75
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	10202.76	121.09	17.12	41.34	14.20	10.44	9.60	6.68	3.34
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	9233.74	161.23	33.92	29.27	19.51	9.76	11.15	12.55	6.50
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	10373.59	151.20	42.82	36.80	14.72	7.36	5.35	3.35	4.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	13230.27	186.59	29.41	40.10	21.39	10.16	10.16	8.02	4.28
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	11382.17	264.68	56.57	40.01	18.18	14.95	11.31	15.76	15.76
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	11122.35	124.82	33.04	24.78	17.44	13.77	10.10	6.42	4.59
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	14027.47	235.61	28.45	38.23	16.00	10.67	8.89	4.45	3.56
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	13181.08	230.23	51.86	41.03	18.81	11.40	17.10	9.12	15.39
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	12812.58	149.55	27.61	31.44	17.64	11.50	3.83	8.44	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	15403.02	183.85	26.26	38.30	23.53	13.13	12.04	5.47	5.47
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	14261.44	220.05	49.89	40.09	20.94	15.15	11.14	11.14	9.80
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	13822.85	72.27	30.93	14.82	20.54	7.54	9.36	5.98	5.20
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	14845.64	157.16	23.21	37.80	21.22	10.61	11.94	8.62	5.97
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	11991.50	282.69	39.49	22.86	20.79	18.71	20.79	18.71	8.31
Macrophage - monocyte derived, donor1	11232-116C8	1538.20	4.79	1.60	0.46	1.82	0.68	1.14	1.14	0.46
Macrophage - monocyte derived, donor2	11313-117C8	3398.37	10.09	2.39	2.39	2.20	1.84	0.92	0.92	0.00
Macrophage - monocyte derived, donor3	11389-118C3	2960.60	21.76	6.69	5.77	4.19	1.97	2.10	0.79	0.92
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	3891.32	5.84	3.72	3.19	1.59	1.59	0.53	0.53	2.66
Mallassez-derived cells, donor2	11929-125I3	8891.07	36.60	7.76	7.76	3.80	3.80	2.54	1.58	0.79
Mallassez-derived cells, donor3	11930-125I4	10182.22	43.50	4.45	3.61	5.84	2.50	2.22	1.53	2.36
Mammary Epithelial Cell, donor1	11273-116H4	3348.42	7.47	2.09	1.10	1.20	0.80	0.80	0.50	0.20
Mammary Epithelial Cell, donor2	11350-117G9	5451.35	15.93	5.50	4.05	1.45	1.16	1.16	0.29	1.45
Mammary Epithelial Cell, donor3	11422-118F9	8350.81	26.69	11.97	10.48	6.98	4.74	3.24	1.50	2.00
Mast cell - stimulated, donor1	11487-119E2	3260.20	6.10	6.10	4.75	3.39	0.00	3.39	0.00	0.68
Mast cell, donor1	11563-120D6	1727.01	7.35	2.60	1.95	3.14	1.95	0.22	2.16	0.22
Mast cell, donor2	11565-120D8	1214.25	8.62	3.86	7.13	3.57	1.78	0.30	4.46	2.08
Mast cell, donor3	11566-120D9	768.13	6.75	2.70	2.03	3.38	0.90	0.00	4.73	0.68
Mast cell, donor4	11567-120E1	961.79	10.11	2.48	2.66	3.55	1.06	0.00	4.43	1.24
Mast cell, expanded and stimulated, donor5	11940-126A5	4983.75	18.08	5.54	4.32	2.77	2.55	0.67	1.89	0.78
Mast cell, expanded and stimulated, donor8	11942-126A7	2654.59	12.26	1.17	1.75	0.00	0.00	0.00	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	2777.99	16.75	5.16	4.70	3.10	1.49	1.38	2.18	1.03
Mast cell, expanded, donor8	11941-126A6	1667.65	14.23	1.51	1.34	1.51	1.51	0.17	1.67	0.50
Melanocyte - dark, donor1	11502-119F8	5977.14	16.22	5.57	4.68	2.89	2.49	2.79	1.69	1.19
Melanocyte - dark, donor2	11582-120F7	6182.77	32.53	8.31	7.96	1.73	4.50	3.11	1.38	2.77
Melanocyte - dark, donor3	11663-122F7	4229.96	7.82	2.32	2.03	1.01	1.45	1.01	0.58	0.22
Melanocyte - light, donor1	11274-116H5	4277.84	19.98	4.94	2.59	3.29	3.06	1.88	2.59	1.88
Melanocyte - light, donor2	11351-117H1	7929.57	41.63	3.41	5.46	10.24	4.09	0.68	3.41	5.46
Melanocyte - light, donor3	11423-118G1	4486.14	35.56	11.27	6.07	4.34	4.34	2.60	2.60	3.47
Melanocyte, donor1 (MC+1)	12641-134G4	3938.96	59.25	10.83	13.64	3.75	3.75	9.37	3.75	2.29
Melanocyte, donor2 (MC+2)	12739-135I3	3207.14	23.40	5.92	4.03	4.57	2.15	2.42	3.50	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	4513.89	34.55	4.82	5.62	2.95	3.21	0.80	1.34	1.34
Meningeal Cells, donor1	11493-119E8	11261.40	16.13	3.23	3.23	2.98	2.36	1.74	0.12	0.99
Meningeal Cells, donor2	11573-120E7	6991.74	39.61	9.24	13.64	3.08	1.76	4.40	0.88	1.76
Meningeal Cells, donor3	11654-122E7	7354.22	24.04	8.80	3.83	2.85	1.63	2.53	2.12	1.39
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	5803.78	16.54	8.84	7.13	3.14	2.57	4.28	1.43	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	4190.52	14.69	5.94	2.72	2.92	1.31	0.91	1.21	1.61
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	26624.97	59.14	3.94	10.51	2.63	3.94	2.63	2.63	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	6607.52	36.63	11.77	0.00	5.23	2.62	2.62	1.31	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	5134.47	33.01	11.48	5.74	5.02	5.74	5.02	3.59	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	6419.75	38.33	6.99	8.05	6.78	3.81	1.48	3.39	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	6628.89	57.80	19.60	9.55	13.07	4.52	6.03	4.02	3.02
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	10632.31	17.14	7.03	4.18	5.05	1.54	2.42	0.88	1.76
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	9765.77	56.26	19.00	10.23	14.61	3.65	2.92	1.46	4.38
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	9142.88	54.22	13.09	8.18	9.00	4.91	4.50	4.30	3.48
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	7164.98	24.24	5.54	5.12	4.02	2.63	2.63	0.55	1.80
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5648.72	21.93	2.97	1.49	2.97	2.97	1.12	0.74	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	4612.73	15.66	4.47	2.76	1.71	1.84	2.11	2.89	0.79
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	3040.40	8.90	1.78	1.19	1.78	1.19	0.59	0.59	1.19
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	6768.41	32.70	2.34	4.67	4.67	0.00	2.34	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	8868.27	35.86	8.33	8.33	5.76	3.84	5.12	1.92	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	4473.80	11.34	4.25	3.54	1.77	1.77	1.42	2.13	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	4026.63	14.70	3.75	4.69	1.56	1.56	3.13	3.13	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	7291.75	31.20	5.81	20.32	4.35	3.63	4.35	2.18	2.18
Mesothelial Cells, donor1	11247-116E5	3327.15	26.25	7.69	8.75	5.30	2.65	1.86	1.86	1.06
Mesothelial Cells, donor2	12156-128G5	4870.54	20.02	7.51	5.51	2.00	0.50	0.50	0.50	1.00
Mesothelial Cells, donor3	11402-118D7	4589.52	36.93	16.84	10.33	5.71	2.38	3.61	1.88	1.66
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	5328.38	4.05	2.70	0.00	2.70	0.00	0.00	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	2949.14	25.12	4.93	2.96	2.46	0.74	1.72	0.00	2.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	2625.69	13.84	3.24	1.47	2.06	0.59	0.88	0.88	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3225.45	0.00	3.46	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	2187.29	23.25	1.55	3.10	1.86	1.86	0.93	0.62	1.24
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	2047.99	11.82	2.70	1.04	1.45	0.62	0.21	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2190.98	2.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	2272.13	25.53	3.50	4.50	2.25	1.25	1.50	0.00	1.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	2722.59	7.45	2.79	0.93	2.33	0.00	0.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	2258.07	0.00	0.00	0.00	0.00	0.00	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	2230.90	21.54	3.45	3.05	2.85	1.02	1.42	0.81	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	2322.72	7.92	0.40	3.56	0.40	1.98	0.79	0.40	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	1308.38	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	2278.71	34.51	3.54	4.42	0.88	2.65	0.00	0.88	2.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	2363.59	13.30	4.56	1.14	2.66	0.76	1.52	0.76	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2455.48	5.26	3.95	1.32	1.32	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	2320.89	29.71	6.37	4.46	1.27	1.27	0.64	0.64	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	1863.75	2.76	1.84	0.00	0.92	0.00	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	2135.57	15.80	4.17	1.19	0.89	1.19	1.79	0.00	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	1651.53	3.35	1.68	0.00	3.35	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	1222.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	1998.44	27.85	7.78	4.52	3.76	1.00	1.76	1.51	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	1768.25	9.27	1.90	1.66	0.95	0.24	0.24	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	1857.69	4.98	2.21	0.55	0.55	0.00	0.55	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	2234.31	19.80	4.84	2.76	1.84	0.92	1.15	0.69	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	2045.97	10.31	2.31	0.42	1.89	0.63	0.21	0.63	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	2559.27	14.27	5.91	2.65	1.43	0.41	0.00	0.20	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	2115.14	20.60	2.57	3.86	1.72	1.07	0.86	0.00	1.72
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	1979.72	6.22	1.78	0.44	1.78	0.67	0.22	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	1300.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	2122.27	12.92	2.41	1.53	1.97	0.44	0.22	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	2186.00	3.55	3.55	2.03	0.00	0.51	1.52	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	2427.50	1.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	2390.95	17.12	2.99	2.72	1.90	0.54	0.82	0.54	1.09
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	2216.80	7.65	2.06	1.18	0.88	0.59	0.00	0.00	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	2326.75	6.54	5.45	1.09	0.00	1.09	1.09	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	2440.26	19.70	5.29	7.21	0.48	1.44	1.44	1.92	1.44
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	1887.08	11.61	3.20	4.00	1.60	1.20	2.80	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	2347.52	2.74	0.00	0.00	0.00	0.00	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	2601.50	18.02	4.00	3.50	1.00	2.00	1.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	2021.04	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	1534.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	2274.57	17.52	3.07	2.19	2.19	0.00	0.88	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2243.73	3.31	1.10	1.10	2.21	0.00	0.00	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	2655.05	3.84	1.92	0.00	0.00	0.64	1.28	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	2678.76	21.82	1.98	1.74	1.24	0.74	0.99	0.25	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	2284.63	4.18	0.00	0.70	2.78	0.70	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2985.54	4.42	4.42	2.21	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	2792.10	29.06	7.52	2.05	2.05	0.68	0.68	0.68	1.37
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	2403.38	10.50	2.19	0.88	1.31	0.88	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	2257.70	4.97	0.71	0.36	0.00	0.00	0.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	3427.78	34.79	5.05	5.61	1.96	1.12	1.12	0.84	1.68
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	1979.64	12.05	2.49	1.66	0.83	0.42	0.00	0.00	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	2365.37	4.66	3.50	1.17	1.75	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	2635.04	19.31	3.02	7.54	3.02	0.90	1.21	0.90	1.51
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	1674.57	10.02	3.76	2.92	2.92	0.42	0.42	0.42	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	1848.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	2532.39	36.02	6.46	5.54	0.92	0.00	0.92	0.00	4.62
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	1981.67	17.07	2.28	1.71	3.41	1.14	1.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	1799.12	9.12	2.76	0.83	1.11	0.28	0.41	0.14	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	2217.27	18.66	6.48	3.11	1.81	0.52	1.30	1.04	1.55
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	1502.70	6.01	0.43	0.00	1.29	1.29	0.43	0.43	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	1782.35	3.81	1.27	0.00	0.00	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	1929.88	9.34	2.40	1.60	0.80	0.27	0.27	0.00	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	1196.42	4.79	1.20	0.60	1.80	0.30	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	1168.88	7.06	0.71	0.28	0.42	0.71	0.42	0.14	0.71
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	1860.44	21.66	4.78	1.59	0.96	1.27	0.32	0.32	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	1152.09	6.63	1.55	1.11	1.11	0.44	0.44	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	1790.58	3.79	1.52	0.38	0.76	0.76	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	1764.01	15.63	3.69	1.42	0.57	0.00	0.28	0.28	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	1249.42	10.32	2.46	2.46	1.47	0.98	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	1219.28	3.91	1.96	0.00	2.61	0.65	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	1640.09	11.17	2.06	1.18	1.76	0.59	0.29	0.29	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	1024.13	10.09	2.02	2.31	1.44	0.29	0.00	0.58	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	1770.16	5.36	1.65	1.24	1.65	0.82	0.00	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	1472.24	8.64	1.49	1.19	0.89	1.19	0.60	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	2248.82	33.90	0.00	3.77	7.53	0.00	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1889.19	17.82	1.78	1.78	1.78	0.00	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	2182.37	18.73	5.59	3.29	2.63	1.64	0.99	0.99	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	2612.00	38.92	3.16	2.10	3.16	0.00	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	2271.42	5.93	2.57	0.79	1.38	0.40	0.79	1.19	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	3221.44	9.31	7.45	2.79	2.79	0.00	0.00	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	2768.03	20.65	6.01	5.26	2.25	1.13	2.25	0.38	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	2538.78	20.77	4.79	5.59	2.93	0.80	1.33	1.07	1.07
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	2207.73	5.88	1.47	0.90	0.45	0.34	0.23	0.68	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	2359.73	22.84	3.68	2.21	2.21	2.21	0.74	1.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	2168.13	19.79	3.66	3.30	3.30	2.20	1.47	1.47	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	2571.40	60.67	14.00	9.33	6.22	6.22	1.56	0.00	6.22
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	1329.68	3.74	0.00	0.00	1.07	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	2275.84	15.46	15.46	3.86	0.00	0.00	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	2577.37	25.25	5.05	5.05	1.01	2.02	0.00	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	1380.03	10.96	1.69	2.53	0.84	0.42	0.00	0.84	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	495.75	0.00	0.00	0.00	0.00	0.00	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	163.40	0.00	0.00	0.00	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	149.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	309.64	1.51	0.00	0.00	1.51	0.00	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	2107.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	913.49	6.52	3.26	0.00	6.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	1192.87	4.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	727.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	7627.30	27.14	7.97	4.96	6.03	2.15	1.51	0.86	1.51
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	7683.97	50.17	9.41	9.93	12.02	2.09	4.70	2.61	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	7969.14	39.38	7.34	4.67	8.01	3.34	6.01	0.67	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	5870.32	15.03	12.10	3.76	8.76	1.25	2.09	0.83	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	4571.57	50.20	24.72	8.75	13.69	2.85	4.56	1.71	2.47
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	6728.12	9.58	12.77	0.00	4.79	1.60	1.60	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6349.32	31.28	11.56	6.12	7.48	3.40	8.16	2.72	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	1086.05	14.70	1.84	3.68	5.51	1.84	1.84	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	4995.21	44.36	9.63	8.37	6.28	7.53	3.77	3.77	2.51
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	4763.36	24.87	12.78	5.35	6.74	3.49	2.09	1.63	1.63
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	6707.31	52.15	17.02	9.19	8.65	4.86	4.32	0.81	3.51
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	4413.50	22.92	5.05	4.63	3.57	1.89	1.68	0.84	1.05
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	1380.71	11.13	11.13	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	7241.84	62.54	15.39	18.86	8.93	5.46	2.98	4.47	2.98
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	3618.59	29.50	11.10	6.23	8.66	4.87	2.17	1.89	1.62
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	5519.48	61.43	19.72	15.19	13.60	7.03	5.21	3.63	1.36
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	4642.01	32.99	7.68	4.57	6.04	3.27	1.96	2.61	1.14
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	4583.71	48.66	7.11	9.66	3.83	2.92	2.19	1.09	2.37
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	7935.32	65.77	15.38	12.73	10.08	6.90	5.83	2.12	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	6969.55	52.23	17.41	9.60	14.41	7.20	4.20	3.00	3.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	3311.96	45.62	12.47	4.92	2.95	3.28	2.30	1.64	1.97
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	5235.51	45.86	11.87	10.73	9.59	6.83	2.60	2.11	1.46
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	5010.84	25.05	4.76	1.59	2.65	1.76	1.23	0.71	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	6424.02	45.01	14.06	9.85	12.66	7.03	4.22	1.41	2.81
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	5992.77	43.67	11.03	10.11	7.36	7.36	3.68	2.30	2.30
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	5222.17	48.20	17.67	12.85	9.00	7.71	3.21	3.86	3.86
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	3058.12	60.70	26.56	11.73	18.28	7.93	7.59	5.52	3.79
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	1807.84	2.53	7.59	5.06	2.53	0.00	2.53	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	4541.90	16.49	4.23	3.56	4.01	2.67	0.67	0.67	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	5020.58	31.33	10.58	9.74	6.35	3.39	1.69	2.12	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	4057.76	39.40	14.48	4.98	7.12	4.03	1.42	1.42	1.19
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	5857.10	58.81	18.03	16.31	13.31	12.02	4.29	4.29	3.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	1155.55	9.03	0.00	0.00	0.00	0.00	0.00	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	6110.95	37.99	14.00	7.33	9.33	3.33	2.00	3.00	2.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	4345.87	12.62	2.25	1.80	3.16	0.90	1.80	2.25	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	4513.60	28.17	5.56	7.14	7.94	5.16	2.38	3.17	2.38
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	5131.69	55.72	18.57	13.00	21.36	10.22	4.64	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	3990.31	53.35	9.08	14.00	7.19	8.70	1.89	4.16	1.51
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	4536.33	38.13	9.45	8.15	11.73	7.82	7.50	2.61	1.63
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	4869.03	23.53	8.72	5.23	5.67	3.05	3.05	1.74	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	5516.54	14.02	6.78	0.90	4.98	0.00	2.26	0.00	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7095.84	52.91	10.58	7.06	7.94	5.29	1.76	2.65	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	5155.21	51.19	11.97	9.97	15.96	9.31	5.32	4.65	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	5656.39	52.08	13.39	15.87	23.81	9.92	6.45	6.45	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	4824.76	30.63	8.42	4.59	8.42	3.06	4.59	3.06	1.53
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	2826.36	33.57	11.49	6.65	5.44	4.84	2.12	3.33	1.81
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	5023.43	25.42	4.42	2.65	5.53	1.77	1.77	0.44	0.88
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	5009.23	47.44	14.23	12.20	14.91	6.10	5.42	5.42	2.03
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	781.76	0.00	5.11	0.00	0.00	5.11	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	4872.58	49.38	14.02	11.58	13.41	7.32	4.88	4.27	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	4809.47	14.79	7.87	2.52	8.18	3.15	3.78	1.89	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	4022.56	26.33	9.99	3.93	7.57	6.96	5.45	2.72	2.72
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7862.34	94.15	25.32	23.73	22.94	11.08	11.87	1.58	3.16
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	3196.88	39.68	21.54	3.40	3.40	9.07	2.27	3.40	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	647.41	25.29	0.00	0.00	15.17	0.00	0.00	0.00	5.06
Myoblast, donor1	11241-116D8	5804.95	30.93	9.81	8.20	7.95	2.48	4.35	2.24	1.37
Myoblast, donor2	11322-117D8	5313.30	70.96	19.95	6.52	10.36	6.14	4.03	2.30	1.53
Myoblast, donor3	11398-118D3	7224.94	16.82	5.04	3.87	4.20	2.52	1.51	1.01	1.01
NK T cell leukemia cell line:KHYG-1	10777-110G3	5285.25	16.49	5.84	3.50	3.50	1.17	1.31	1.17	0.29
Natural Killer Cells, donor1	11230-116C6	1539.74	3.08	1.23	1.54	1.54	0.31	0.31	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	2311.13	21.11	7.54	6.94	3.32	2.11	0.90	1.81	0.00
Natural Killer Cells, donor3	11387-118C1	1665.87	12.33	1.84	2.21	1.84	0.92	0.92	0.74	0.74
Neural stem cells, donor1	11275-116H6	6244.74	25.04	11.61	2.18	3.63	5.08	1.09	0.73	1.45
Neural stem cells, donor2	11352-117H2	7554.30	23.11	3.85	1.93	3.85	0.00	0.00	5.78	0.00
Neurons, donor1	11494-119E9	9675.55	102.41	14.79	9.10	6.83	6.83	1.14	2.28	3.41
Neurons, donor2	11574-120E8	6194.29	25.32	10.35	4.40	3.08	3.96	2.64	2.42	0.88
Neurons, donor3	11655-122E8	7137.22	108.53	32.06	23.84	24.66	8.22	20.55	22.20	6.58
Neutrophils, donor1	11233-116C9	1167.43	6.50	1.86	0.00	1.86	0.00	0.93	0.00	0.00
Neutrophils, donor2	11314-117C9	878.36	11.60	5.80	5.80	5.80	5.80	0.00	0.00	2.90
Neutrophils, donor3	11390-118C4	1547.26	11.00	4.28	3.05	1.83	0.61	0.00	2.44	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	4913.99	31.58	7.48	4.87	2.14	3.09	4.16	2.37	2.14
Nucleus Pulposus Cell, donor2	11409-118E5	3610.61	59.26	8.14	3.58	5.21	1.95	1.95	2.28	2.28
Nucleus Pulposus Cell, donor3	11462-119B4	3457.52	27.28	8.42	10.63	5.62	3.41	3.61	0.40	1.60
Olfactory epithelial cells, donor1	11933-125I7	7556.95	52.03	15.00	9.64	12.11	7.16	6.47	4.54	2.06
Olfactory epithelial cells, donor2	11934-125I8	6952.55	152.13	40.53	35.03	19.83	12.16	20.41	26.49	6.66
Olfactory epithelial cells, donor3	11935-125I9	5818.72	50.40	15.32	12.71	7.83	3.63	5.90	4.77	2.04
Olfactory epithelial cells, donor4	11936-126A1	11137.96	49.28	14.71	7.21	10.62	5.55	4.68	3.41	2.73
Oligodendrocyte - precursors, donor1	11496-119F2	6028.43	16.85	6.02	4.21	3.01	0.60	3.01	0.00	2.41
Osteoblast - differentiated, donor1	11276-116H7	6372.74	28.50	5.53	5.10	8.08	5.53	0.64	2.55	3.40
Osteoblast - differentiated, donor2	11353-117H3	2391.39	56.01	24.01	6.86	25.15	10.29	0.00	9.14	3.43
Osteoblast - differentiated, donor3	11425-118G3	3559.15	51.52	9.93	6.83	9.93	8.69	3.72	1.86	2.48
Osteoblast, donor1	11277-116H8	14533.28	44.17	14.46	9.77	15.05	5.28	2.74	3.91	2.15
Osteoblast, donor2	11354-117H4	10222.93	25.28	8.43	4.21	4.92	1.40	1.40	2.11	0.70
Osteoblast, donor3	11426-118G4	10667.02	47.28	22.75	17.42	12.44	6.40	4.09	2.49	3.02
Pancreatic stromal cells, donor1	11249-116E7	5713.61	45.99	10.02	8.93	5.14	9.27	4.38	4.63	1.94
Pericytes, donor1	11491-119E6	9309.43	31.04	3.34	4.78	4.12	3.56	2.00	0.67	1.56
Pericytes, donor2	11571-120E5	4934.32	42.33	6.56	12.22	4.07	2.72	4.30	0.23	0.91
Pericytes, donor3	11652-122E5	10120.61	74.26	12.82	12.21	10.38	4.48	5.09	3.46	4.27
Perineurial Cells, donor1	11499-119F5	5966.28	11.53	3.39	3.96	2.15	0.79	1.81	1.24	0.68
Perineurial Cells, donor2	11579-120F4	5885.84	10.21	3.96	4.14	2.48	1.84	2.12	1.66	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	1850.60	2.55	0.32	0.32	0.96	0.32	0.32	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	1152.81	20.57	4.90	1.22	0.73	0.98	0.98	0.98	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	1750.99	13.07	2.72	2.46	1.04	1.55	0.91	1.04	0.78
Placental Epithelial Cells, donor1	11278-116H9	1615.33	7.65	2.15	2.63	1.43	1.20	0.48	0.96	0.48
Placental Epithelial Cells, donor2	11355-117H5	2992.88	18.85	1.11	5.54	1.11	1.11	0.00	2.22	0.00
Placental Epithelial Cells, donor3	11427-118G5	3352.88	27.49	8.83	8.64	3.34	3.14	2.16	2.16	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8485.04	139.24	34.18	38.92	17.40	11.08	10.76	12.34	3.80
Preadipocyte - breast, donor1	11467-119B9	5002.21	27.01	3.19	3.56	2.81	2.63	1.13	0.19	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	8255.60	17.36	10.31	6.53	5.48	2.09	2.61	1.57	1.70
Preadipocyte - breast, donor2	11328-117E5	6464.47	80.83	27.02	20.71	9.68	9.46	6.08	2.03	2.70
Preadipocyte - omental, donor1	11468-119C1	3164.26	25.25	7.46	2.88	4.90	2.56	1.28	1.39	0.85
Preadipocyte - omental, donor2	11329-117E6	7174.27	27.93	6.55	6.55	6.98	2.18	0.44	3.06	3.06
Preadipocyte - omental, donor3	11403-118D8	7177.61	39.97	14.75	7.88	11.89	3.58	3.01	2.72	2.15
Preadipocyte - perirenal, donor1	11469-119C2	4003.02	38.39	3.94	19.69	5.91	2.95	2.95	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	10023.09	22.11	8.91	5.53	6.14	2.76	1.54	1.84	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	8891.40	104.12	35.95	18.42	9.56	7.26	8.50	4.60	3.36
Preadipocyte - subcutaneous, donor3	11428-118G6	5281.38	55.51	17.20	17.88	10.22	7.66	6.30	4.94	1.70
Preadipocyte - visceral, donor1	11280-116I2	5707.04	18.63	5.40	3.17	3.26	2.98	1.02	2.42	0.65
Preadipocyte - visceral, donor2	11357-117H7	4860.88	56.60	14.73	5.06	2.76	2.30	2.76	3.22	0.00
Preadipocyte - visceral, donor3	11429-118G7	6677.79	82.65	15.26	28.84	8.46	7.42	7.00	2.93	1.88
Prostate Epithelial Cells (polarized), donor1	11253-116F2	2542.01	37.56	4.53	6.18	3.92	6.03	1.66	3.77	1.36
Prostate Epithelial Cells, donor2	11331-117E8	3544.18	72.85	19.63	10.02	10.83	10.83	4.06	2.30	1.76
Prostate Epithelial Cells, donor3	11404-118D9	2268.23	23.52	7.78	5.76	3.55	5.51	1.47	1.59	1.10
Prostate Stromal Cells, donor1	11254-116F3	5402.53	38.50	12.76	6.72	6.83	3.99	3.87	2.51	2.28
Prostate Stromal Cells, donor2	11332-117E9	4797.13	63.65	22.23	7.89	6.81	6.81	4.66	3.05	2.15
Prostate Stromal Cells, donor3	11405-118E1	5954.99	77.89	16.89	15.54	8.76	10.74	4.69	4.28	2.50
Renal Cortical Epithelial Cells, donor1	11516-119H4	11562.65	30.66	5.47	3.28	2.92	0.73	1.09	1.82	2.19
Renal Cortical Epithelial Cells, donor2	11596-120H3	7482.97	26.13	6.93	3.53	3.88	1.87	2.43	2.91	1.59
Renal Epithelial Cells, donor1	11517-119H5	12754.32	22.32	7.10	6.09	4.06	2.03	2.03	1.52	2.03
Renal Epithelial Cells, donor2	11597-120H4	10324.81	47.66	7.82	5.69	5.69	3.56	2.13	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	8419.64	24.56	6.25	2.86	2.86	2.86	2.75	1.59	1.06
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4940.26	46.98	10.21	23.83	4.77	4.09	4.77	1.36	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	4710.01	45.28	8.62	12.94	7.41	3.77	4.04	1.75	1.35
Renal Glomerular Endothelial Cells, donor3	11675-122H1	6845.04	57.94	12.65	5.55	4.88	1.78	2.89	2.00	2.66
Renal Glomerular Endothelial Cells, donor4	11783-124B1	6801.50	45.25	10.65	3.99	8.65	4.66	2.66	2.00	2.66
Renal Mesangial Cells, donor1	11518-119H6	10562.03	27.29	4.62	3.08	3.96	2.42	3.74	1.76	1.32
Renal Mesangial Cells, donor2	11598-120H5	9486.90	62.07	15.05	11.91	9.40	5.02	3.76	1.88	3.13
Renal Mesangial Cells, donor3	11679-122H5	8553.42	53.26	13.59	9.71	8.04	5.55	3.88	1.66	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	7323.91	10.74	2.42	1.34	1.34	0.81	0.81	1.07	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	5196.52	32.05	10.12	5.90	1.69	3.37	0.84	2.53	1.69
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	7254.33	39.53	10.80	9.64	10.61	5.21	5.21	3.28	1.74
Retinal Pigment Epithelial Cells, donor0	11215-116A9	5652.34	17.11	5.70	8.30	4.41	1.04	2.59	3.11	1.56
Retinal Pigment Epithelial Cells, donor1	11528-119I7	9267.79	35.25	5.12	6.54	6.54	4.26	2.56	1.99	1.99
Retinal Pigment Epithelial Cells, donor2	11608-120I6	9507.04	51.46	12.35	12.35	11.32	3.09	2.06	2.06	3.09
Retinal Pigment Epithelial Cells, donor3	11689-122I6	4616.45	16.56	4.01	2.26	2.01	1.51	1.00	1.25	1.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	1150.34	11.09	3.21	1.74	1.47	1.20	0.40	0.67	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	2290.69	6.25	0.89	1.79	0.89	0.00	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	3244.43	12.66	4.40	7.15	3.30	3.30	2.20	2.20	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	2497.72	7.54	3.48	1.74	0.00	1.74	1.74	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	4691.18	20.28	4.03	3.12	1.69	0.78	0.91	0.13	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	4229.22	44.99	9.04	10.13	5.36	3.28	2.58	1.59	1.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	4602.22	10.82	3.57	4.57	2.34	1.56	1.90	0.45	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	4274.03	26.92	4.47	6.08	2.73	1.24	2.11	0.62	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	5049.78	59.79	16.43	14.34	6.53	4.31	4.43	3.03	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	4815.40	49.23	12.25	12.25	3.47	3.93	2.77	2.54	2.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	5502.22	26.83	3.29	4.65	2.33	0.68	1.23	0.68	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	4676.61	71.85	21.18	12.56	4.39	2.72	3.03	2.12	4.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	4930.06	7.71	3.40	3.58	2.87	1.08	1.61	0.72	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	5222.10	22.81	3.44	4.88	2.58	2.30	1.43	0.86	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	4795.45	55.37	13.09	11.59	4.40	4.19	3.00	3.00	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	4480.49	32.75	10.62	10.84	5.53	3.32	3.10	1.55	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	6730.36	28.68	2.68	4.21	1.34	1.53	0.00	1.34	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	4924.50	36.89	10.25	6.99	3.17	2.89	1.77	1.12	2.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	5016.37	11.27	3.01	2.07	2.07	1.32	0.94	1.50	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	6330.38	22.96	2.65	3.45	2.39	1.06	1.19	0.40	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	4829.09	50.03	11.39	9.83	3.11	2.14	1.46	1.85	2.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	4627.89	28.26	7.26	5.54	5.35	2.29	3.06	0.95	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	5746.77	24.88	4.16	4.49	3.20	1.82	0.64	0.32	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	4831.35	54.66	13.17	12.89	10.65	2.80	5.61	2.80	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	5077.39	29.22	6.49	6.67	2.91	1.88	2.56	1.71	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	6247.37	27.53	4.19	3.10	2.01	1.46	1.09	1.09	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	4631.94	50.77	10.91	10.55	4.66	3.80	3.80	1.59	2.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	4929.14	41.24	11.82	13.16	6.45	3.09	2.96	2.42	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	6524.95	29.25	2.59	4.48	1.65	0.24	0.24	0.71	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	4752.80	49.40	13.49	13.29	3.77	5.36	3.77	1.59	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	4997.29	47.24	10.99	11.69	4.44	4.21	3.27	2.10	2.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	6166.12	25.09	5.39	4.77	0.83	2.07	1.24	0.21	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	4833.66	88.26	18.58	14.16	6.64	3.98	3.54	1.99	4.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	4856.35	30.71	9.19	9.61	2.72	3.76	1.67	2.30	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	6113.78	29.07	3.90	5.52	2.83	1.48	1.88	0.27	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	5436.32	29.12	5.79	4.77	3.92	1.02	2.21	0.34	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	4946.73	30.65	8.68	6.75	4.43	2.70	2.51	0.58	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	6925.30	52.96	5.33	6.53	1.72	1.38	0.52	0.86	1.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	5351.64	27.02	7.68	5.62	3.70	3.29	2.06	0.41	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	4873.04	52.21	14.28	9.36	4.76	3.94	4.76	1.81	2.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	5503.38	33.57	2.90	4.09	2.22	2.22	0.68	1.02	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	4445.53	26.63	7.25	8.58	2.66	1.92	2.07	1.63	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	5428.04	20.79	8.00	4.00	5.33	2.67	0.80	1.07	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	2800.45	16.73	1.80	2.49	2.35	0.97	0.83	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	4046.31	28.57	7.14	12.62	3.10	4.52	1.67	0.95	2.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	5327.95	22.37	5.64	3.43	3.43	2.22	0.60	0.60	1.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	4135.95	34.84	4.05	6.03	3.20	1.60	1.41	0.85	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	3459.74	46.47	7.69	8.73	3.14	6.29	3.49	2.45	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	2911.82	11.48	3.02	0.91	0.91	1.81	0.00	0.60	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	4496.12	38.06	4.53	6.85	3.43	5.02	1.47	0.98	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	2370.90	7.28	2.33	1.60	1.89	0.44	0.44	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	3564.17	34.07	6.69	7.30	1.22	3.65	1.22	1.22	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	4757.58	33.15	4.22	4.22	3.32	3.32	1.81	1.21	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	2531.50	39.13	10.40	11.08	5.65	8.60	1.36	4.30	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	2903.74	26.96	8.39	6.29	2.40	3.00	0.60	1.80	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	2481.21	47.23	5.90	6.85	4.84	6.14	1.18	1.18	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	1944.06	40.34	17.93	7.47	10.89	6.19	0.64	2.56	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	1923.73	22.24	8.41	2.40	3.61	1.80	0.60	1.20	1.80
Schwann Cells, donor1	11498-119F4	11579.35	78.80	15.61	28.59	10.72	6.58	7.90	1.50	2.44
Schwann Cells, donor2	11578-120F3	6692.55	40.83	6.80	6.80	10.21	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	6252.36	63.10	10.73	5.48	4.16	4.60	3.29	2.85	3.07
Sebocyte, donor1	11220-116B5	7213.03	19.72	12.05	2.74	4.38	3.83	0.55	1.10	1.10
Sebocyte, donor2	11301-117B5	3918.16	46.42	18.38	7.35	7.35	4.60	0.92	2.30	1.38
Sebocyte, donor3	11378-118B1	3735.17	34.42	15.87	8.86	5.57	3.09	2.27	1.65	2.47
Sertoli Cells, donor1	11255-116F4	5866.01	64.61	16.57	4.97	1.66	4.97	4.97	0.00	0.00
Sertoli Cells, donor2	11333-117F1	3578.47	118.62	31.07	14.12	8.47	8.47	2.82	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	3566.89	19.97	3.34	2.29	3.96	3.17	0.79	1.58	0.44
Skeletal Muscle Cells, donor2	11358-117H8	2373.10	28.19	9.40	6.51	7.23	3.61	2.17	6.51	2.17
Skeletal Muscle Cells, donor3	11430-118G8	14299.60	112.03	33.44	31.77	26.75	10.87	6.69	4.18	2.51
Skeletal Muscle Cells, donor4	11451-119A2	6123.67	62.84	13.20	14.14	8.33	6.60	4.56	2.36	3.61
Skeletal Muscle Cells, donor5	11455-119A6	5541.47	60.65	12.19	17.09	9.96	5.35	3.86	1.64	1.93
Skeletal Muscle Cells, donor6	11459-119B1	4595.68	53.71	9.85	12.31	7.54	5.85	5.69	0.92	1.85
Skeletal Muscle Satellite Cells, donor1	11240-116D7	6195.22	34.78	8.57	8.69	4.54	4.54	3.53	2.27	1.01
Skeletal Muscle Satellite Cells, donor2	11321-117D7	5189.01	69.77	20.40	11.99	8.42	5.28	4.14	4.00	1.28
Skeletal Muscle Satellite Cells, donor3	11397-118D2	6427.22	39.98	16.77	12.40	7.64	3.87	3.87	2.88	1.09
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	3718.97	9.35	3.03	1.60	3.71	2.19	0.59	0.76	0.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	7397.59	33.29	11.58	13.03	10.86	3.62	7.24	2.90	2.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	7394.56	75.40	18.71	33.71	12.52	8.67	2.61	2.20	3.30
Skin - palm, donor1	10286-104F7	738.68	5.37	2.69	2.69	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	6279.02	71.21	11.39	12.69	7.93	13.26	6.05	6.05	2.59
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	5717.88	52.35	9.00	5.73	3.27	0.82	3.27	1.64	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	8005.55	95.03	19.34	17.66	10.78	8.05	7.66	2.86	4.02
Small Airway Epithelial Cells, donor1	11256-116F5	2770.43	23.63	6.53	5.28	3.20	6.26	1.39	2.09	1.11
Small Airway Epithelial Cells, donor2	11334-117F2	3512.21	30.38	5.06	3.09	3.09	2.81	0.70	1.13	0.98
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	4198.26	7.61	5.07	2.11	1.90	1.27	2.11	0.42	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	3041.27	16.11	4.42	3.75	3.90	2.40	1.20	0.97	1.05
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	6855.81	69.43	5.86	9.26	5.25	3.39	2.16	1.54	2.47
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	3985.28	28.24	3.78	3.11	11.12	1.11	1.11	1.11	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	6121.04	17.63	7.05	2.94	4.70	2.35	1.76	3.53	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	3823.59	11.27	9.06	2.87	2.65	1.55	1.77	0.88	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	7369.20	20.87	6.69	1.97	6.30	0.39	2.76	2.36	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	7101.44	10.82	1.55	0.77	6.18	0.77	0.00	0.77	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	3703.80	38.03	6.00	7.01	2.00	3.00	2.00	2.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	11403.02	46.04	13.17	6.52	8.92	4.92	2.53	4.26	2.79
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	4575.39	68.71	13.74	11.53	5.98	4.43	6.65	2.22	1.99
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	5947.39	60.17	20.48	12.03	11.52	3.33	2.30	0.77	2.30
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	5000.09	11.40	4.56	4.88	2.28	2.28	0.33	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	5586.38	19.20	4.73	4.43	5.61	0.30	1.48	1.77	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	6662.36	39.43	15.80	14.95	8.54	4.27	3.70	1.99	2.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	11709.16	16.27	5.21	3.09	4.72	3.42	2.11	0.81	0.81
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	6446.37	31.36	4.57	1.83	2.74	1.83	1.52	1.83	2.44
Smooth Muscle Cells - Carotid, donor1	11285-116I7	7248.82	23.49	6.06	3.54	4.29	1.52	0.76	0.76	1.77
Smooth Muscle Cells - Carotid, donor2	11362-117I3	3427.60	30.60	6.12	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	10670.65	125.88	30.52	14.78	7.15	10.49	6.68	1.43	2.86
Smooth Muscle Cells - Colonic, donor1	11239-116D6	4070.58	13.42	6.34	2.80	2.06	1.03	2.21	1.18	0.88
Smooth Muscle Cells - Colonic, donor2	11320-117D6	5389.15	62.63	11.84	8.61	5.81	3.44	3.23	2.37	2.15
Smooth Muscle Cells - Colonic, donor3	11396-118D1	5887.52	55.73	11.55	12.18	7.56	5.77	3.36	1.89	3.46
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	7847.16	19.49	9.59	7.27	5.10	2.32	1.86	2.63	2.32
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	6306.66	52.82	16.17	7.55	8.62	4.31	0.00	1.08	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	5253.89	43.63	15.24	11.95	9.86	4.18	2.09	1.79	1.49
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	13568.57	18.78	4.78	3.41	6.83	2.05	1.37	3.76	1.37
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	7135.47	18.85	4.55	3.06	1.57	2.43	2.67	2.67	1.10
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	5905.82	69.24	11.47	4.53	9.66	7.55	0.60	6.84	1.21
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	2502.63	24.12	7.05	6.37	3.64	3.41	2.50	3.41	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	7641.83	125.59	20.53	12.08	10.26	6.64	2.42	0.00	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	8078.38	21.72	7.95	4.77	6.36	2.65	4.77	1.59	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	3821.67	16.38	2.66	3.73	2.40	3.60	0.53	0.80	0.93
Smooth Muscle Cells - Prostate, donor2	11335-117F3	3625.36	60.36	16.53	9.77	9.77	8.89	2.38	3.38	1.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	4517.22	21.81	5.83	3.55	7.61	2.54	2.03	2.28	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	8023.24	27.74	6.03	4.67	4.98	3.47	1.81	1.06	0.90
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	3101.19	25.51	6.75	6.75	2.25	3.75	0.75	2.25	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	6141.90	55.57	104.67	14.21	1.29	2.58	5.17	2.58	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	7433.68	23.72	10.23	8.84	2.33	0.93	1.40	6.05	3.72
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	9160.08	91.38	17.67	13.63	8.08	9.09	7.07	3.53	1.51
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	5978.00	54.84	21.62	14.73	15.98	4.70	2.51	2.51	2.51
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	6500.01	15.93	3.83	3.24	3.54	2.65	1.18	0.88	0.88
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	7361.15	2.83	1.25	1.83	2.00	0.83	0.92	0.50	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	7059.24	32.70	7.01	6.07	7.47	3.74	2.80	1.40	1.87
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	12255.79	24.47	9.79	12.09	8.64	4.75	2.73	3.17	3.17
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	12543.81	85.67	36.71	33.91	18.36	9.69	9.18	8.16	3.82
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	7469.81	67.69	18.05	19.18	10.15	7.33	5.45	3.38	1.69
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	6650.85	16.63	4.33	3.21	2.79	1.68	2.93	0.84	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	8236.21	15.84	5.95	5.03	4.02	1.17	3.18	2.35	1.26
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	4099.92	23.33	3.81	5.71	4.29	0.95	1.90	1.43	2.38
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	10677.04	34.25	14.19	12.23	11.74	3.18	2.69	1.96	2.20
Smooth Muscle Cells - Uterine, donor1	11258-116F7	8196.96	63.41	11.27	10.83	7.95	9.28	5.30	2.21	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	6312.97	31.31	9.36	6.44	5.27	3.22	2.63	3.80	2.93
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	2672.27	28.38	3.50	3.11	1.55	0.78	0.58	0.39	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	5297.26	45.49	8.46	6.08	5.55	1.85	2.38	1.59	1.59
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	2999.01	35.33	9.67	5.95	5.95	2.60	2.23	1.49	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	8222.35	49.95	7.19	6.11	4.67	2.87	2.87	1.08	2.16
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	4380.29	34.64	6.81	4.26	5.39	2.56	0.85	1.99	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	9114.91	78.38	14.97	9.45	5.12	2.76	6.30	1.97	3.94
Smooth muscle cells - airway, control, donor1	11966-126D4	4035.54	43.17	9.90	7.36	2.54	2.79	1.27	1.02	1.52
Smooth muscle cells - airway, control, donor2	11967-126D5	2811.21	37.54	3.99	3.99	2.00	2.80	0.40	2.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	4948.35	61.86	6.27	7.94	4.18	4.60	0.84	1.67	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	4761.91	30.25	4.58	6.42	1.38	3.21	0.46	0.00	0.00
Synoviocyte, donor1	11291-117A4	8817.99	67.33	14.48	7.91	8.58	5.55	4.38	5.22	1.85
Synoviocyte, donor2	11368-117I9	3856.20	49.78	14.25	15.59	5.70	6.87	5.70	5.36	0.67
Synoviocyte, donor3	11440-118H9	3214.64	47.36	7.37	14.97	4.24	4.47	4.02	2.01	2.01
Trabecular Meshwork Cells, donor1	11532-120A2	12737.43	16.79	4.65	2.14	3.22	0.71	3.22	0.36	1.79
Trabecular Meshwork Cells, donor2	11612-122A1	3187.12	7.93	3.96	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	6336.75	42.37	7.87	6.95	5.79	2.32	3.70	1.85	2.32
Tracheal Epithelial Cells, donor1	11292-117A5	4589.88	13.55	4.80	3.37	2.87	1.08	0.93	1.08	1.15
Tracheal Epithelial Cells, donor2	11369-118A1	7159.14	50.64	17.01	9.28	6.19	5.41	2.71	1.16	2.71
Tracheal Epithelial Cells, donor3	11441-118I1	4072.20	52.68	8.02	13.17	7.44	4.01	1.15	1.15	2.29
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	1185.22	14.52	3.20	1.85	2.34	1.72	0.49	1.23	0.12
Urethra, donor2	10319-105A4	1052.08	17.98	0.00	0.00	3.60	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	8377.09	31.35	6.11	4.78	5.58	2.66	2.92	0.80	1.59
Urothelial Cells, donor2	11600-120H7	4961.80	32.05	7.21	6.01	4.81	3.61	2.80	1.20	2.80
Urothelial Cells, donor3	11681-122H7	5529.80	38.96	13.29	7.79	6.42	3.44	4.13	4.13	3.21
Urothelial cells, donor0	11216-116B1	6258.67	25.19	8.47	4.90	4.46	2.45	2.67	1.34	1.78
Whole blood (ribopure), donor090309, donation1	12179-129A1	2947.85	10.68	2.67	2.67	0.89	0.00	2.67	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	2713.40	7.15	1.43	0.00	0.00	0.00	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	1693.50	24.64	7.53	3.42	0.00	0.68	3.42	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	1968.92	4.13	1.03	1.38	1.03	0.00	1.03	0.00	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	1987.70	10.46	1.74	1.16	0.58	1.16	0.58	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	2313.64	7.29	2.08	0.00	0.00	0.00	3.12	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	2401.86	6.42	0.92	0.92	0.00	0.00	1.84	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	1707.12	28.30	10.04	4.56	2.74	0.91	1.83	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	4195.51	19.61	8.02	3.95	6.54	2.59	2.34	1.36	1.11
Wilms' tumor cell line:HFWT	10597-108E3	1511.03	2.64	0.88	0.88	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	4797.29	13.41	5.31	3.91	4.47	1.68	0.56	1.12	0.56
achilles tendon, donor2	10292-104G4	1475.50	24.80	2.07	0.00	0.00	0.00	2.07	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	1876.22	3.57	2.55	0.76	1.53	0.51	1.02	0.25	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	4058.88	7.89	2.55	2.09	1.86	0.23	1.16	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	2070.98	4.87	2.61	0.83	1.19	0.47	0.24	0.36	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	4148.65	10.34	3.27	3.27	3.27	1.36	0.54	2.18	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	3041.33	25.58	5.90	5.34	2.53	0.84	1.12	0.56	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	5763.07	22.21	5.71	4.02	2.54	1.69	2.54	2.33	1.48
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	3970.48	34.57	11.16	5.99	4.63	1.91	0.27	0.27	1.36
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	8158.87	44.95	12.34	9.25	5.29	2.20	0.88	1.32	2.64
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	3977.42	33.08	8.17	5.31	3.27	2.04	1.63	0.00	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	9749.00	26.79	16.70	10.48	12.43	5.82	4.66	4.66	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	2059.33	18.77	4.97	4.42	2.21	1.10	2.02	0.92	1.47
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	4376.38	62.41	0.00	3.90	3.90	3.90	0.00	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	1338.05	15.10	3.72	2.79	0.93	0.93	0.23	1.16	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	4820.23	38.06	7.25	4.92	5.95	2.59	2.07	1.29	2.07
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	5568.12	47.05	9.64	4.97	5.26	1.75	1.75	1.17	2.63
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	3664.17	16.27	8.37	1.86	2.79	0.00	0.46	0.93	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	1414.30	8.64	6.99	2.06	2.06	0.41	1.65	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	7394.12	33.15	9.21	5.22	3.68	3.68	6.75	1.84	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	4177.91	25.18	9.39	4.69	2.13	0.00	2.13	0.85	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	4893.64	10.01	6.37	2.73	3.34	0.61	0.61	0.91	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	4480.73	13.72	6.98	1.44	2.65	0.48	1.20	0.96	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	3084.71	32.97	6.90	4.01	2.23	0.67	2.23	0.89	1.78
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	3462.55	11.01	2.33	1.33	1.67	0.33	0.67	0.67	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	587.19	0.00	0.00	1.86	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	2242.26	16.57	4.14	1.13	1.51	0.75	0.75	0.75	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	3762.08	12.65	1.74	0.87	3.05	0.87	0.00	0.44	1.74
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	2466.79	0.00	1.87	0.00	1.87	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	3466.79	8.48	4.71	1.41	1.88	0.94	0.47	1.18	1.18
adipose tissue, adult, pool1	10010-101C1	2195.09	21.25	3.88	4.19	3.57	1.71	0.93	1.55	1.24
adipose, donor1	10184-103D4	3625.77	115.52	22.28	19.35	12.90	14.66	7.62	17.59	5.28
adipose, donor2	10185-103D5	3212.11	77.05	8.11	12.17	15.41	12.98	3.65	11.76	0.00
adipose, donor3	10186-103D6	3776.10	70.25	15.79	17.15	15.25	14.98	3.00	12.53	1.91
adipose, donor4	10187-103D7	2843.81	44.20	6.93	6.93	5.20	7.80	0.87	2.60	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	8400.92	18.46	11.84	6.00	8.21	2.53	2.68	1.42	1.26
adrenal gland, adult, pool1	10081-102A9	1891.59	7.28	3.64	3.64	10.91	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	4081.16	12.14	5.20	3.20	4.00	2.40	1.20	1.33	0.80
alveolar cell carcinoma cell line:SW 1573	10708-109H6	2985.60	20.37	6.07	3.57	4.29	1.07	1.43	1.43	1.07
amniotic membrane cells, donor1	12235-129G3	3204.85	13.68	4.87	5.10	2.09	2.32	2.09	0.93	0.46
amniotic membrane cells, donor2	12236-129G4	3057.13	16.23	6.09	4.40	1.69	1.35	1.35	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	3318.68	15.32	4.42	2.65	2.95	0.00	1.77	0.59	1.47
amygdala - adult, donor10196	10167-103B5	2410.73	10.67	2.37	2.37	1.19	1.19	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	1322.65	13.79	5.68	2.43	1.62	0.81	0.61	0.20	0.00
amygdala, newborn, donor10223	10360-105E9	1879.81	10.97	5.49	0.32	3.23	0.32	0.32	0.00	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	6228.98	27.50	4.33	3.18	2.80	2.80	0.76	2.55	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	3522.03	13.02	6.18	5.74	4.63	0.88	1.54	0.88	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	2273.46	6.01	4.01	1.34	4.01	0.67	0.33	1.34	0.33
aorta, adult, pool1	10052-101G7	2880.80	24.91	9.81	4.31	4.71	1.96	2.75	1.37	0.20
appendix, adult	10189-103D9	3349.07	49.29	11.26	4.66	6.99	2.33	1.16	1.16	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	7212.66	20.29	4.47	3.44	3.44	1.72	1.38	2.06	1.38
artery, adult	10190-103E1	917.12	20.38	5.43	0.00	0.00	2.72	0.00	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	4313.27	13.33	4.06	2.32	2.17	1.45	1.01	0.72	0.87
b cell line:RPMI1788	10427-106D4	4464.90	10.11	4.16	2.38	2.38	1.78	1.34	0.74	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	6590.20	39.40	12.76	12.76	11.10	5.83	2.77	3.05	2.22
bile duct carcinoma cell line:HuCCT1	10432-106D9	4462.05	13.20	4.47	2.98	1.79	2.08	1.19	0.40	0.50
bile duct carcinoma cell line:TFK-1	10496-107C1	3822.42	10.88	3.35	2.18	2.34	1.67	0.67	0.00	0.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	4259.16	24.05	9.51	5.59	7.83	2.80	2.80	0.56	0.56
bladder, adult, pool1	10011-101C2	2312.32	19.45	4.13	3.80	2.61	2.06	0.65	0.11	0.76
blood, adult, pool1	10053-101G8	1634.39	31.00	4.43	6.64	6.64	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	5190.32	5.14	0.86	0.86	1.71	0.86	0.00	0.00	1.71
bone marrow, adult	10192-103E3	1967.12	46.56	8.77	4.05	2.70	2.70	2.02	1.35	2.02
brain, adult, donor1	10084-102B3	1610.38	17.43	2.05	6.15	4.10	2.05	2.05	3.08	0.00
brain, adult, pool1	10012-101C3	1822.82	10.69	4.45	2.00	2.45	1.11	0.56	1.34	0.89
brain, fetal, pool1	10085-102B4	7268.88	24.04	10.69	5.34	2.67	0.00	0.00	5.34	0.00
breast carcinoma cell line:MCF7	10482-107A5	6836.89	51.21	14.54	10.90	8.26	2.31	6.61	1.98	1.65
breast carcinoma cell line:MDA-MB-453	10419-106C5	3843.92	5.49	1.37	1.25	1.75	1.00	0.62	0.00	0.50
breast, adult, donor1	10080-102A8	1730.55	16.42	2.53	5.68	3.79	1.26	2.53	1.89	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	2106.03	11.05	4.07	2.03	1.91	0.89	0.76	1.02	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	6526.10	26.28	11.44	5.26	7.11	2.16	2.16	1.55	1.86
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	7011.56	27.17	9.67	5.99	6.91	2.53	3.45	1.84	1.38
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	1848.09	11.14	5.08	2.42	2.42	0.48	0.73	0.48	0.73
carcinoid cell line:NCI-H1770	10703-109H1	718.89	6.11	1.88	1.88	0.94	0.47	0.00	1.41	0.00
carcinoid cell line:NCI-H727	10735-110B6	6397.99	11.38	4.27	5.25	2.52	1.42	0.98	1.31	1.42
carcinoid cell line:SK-PN-DW	10719-109I8	838.19	3.80	1.27	1.27	1.58	0.63	0.63	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	2961.50	25.82	5.32	4.26	1.60	2.93	1.33	1.33	0.27
caudate nucleus - adult, donor10196	10177-103C6	2284.22	16.12	3.45	3.45	3.45	0.00	1.15	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	1773.83	15.90	4.85	2.34	1.67	0.50	1.00	0.33	1.17
caudate nucleus, adult, donor10258	10379-105H1	1590.94	12.99	2.29	3.06	3.06	0.00	0.76	0.76	1.53
caudate nucleus, newborn, donor10223	10354-105E3	2108.77	18.31	1.83	2.56	4.03	1.10	1.83	1.46	1.10
cerebellum - adult, donor10196	10173-103C2	1209.01	8.74	0.00	0.00	2.91	0.00	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	790.63	7.90	3.84	1.49	1.07	0.64	0.43	0.64	0.43
cerebellum, adult, pool1	10083-102B2	1030.70	11.04	2.07	3.79	1.03	2.41	2.07	0.69	0.34
cerebellum, newborn, donor10223	10357-105E6	1643.97	13.28	1.66	0.83	0.83	0.83	1.66	0.00	1.66
cerebral meninges, adult	10188-103D8	2208.99	22.94	5.04	2.02	1.76	1.76	2.27	0.50	0.50
cerebrospinal fluid, donor2	10294-104G6	864.64	9.50	3.65	1.46	2.19	0.73	0.73	0.00	1.46
cervical cancer cell line:D98-AH2	10552-107I3	2762.06	6.04	1.44	0.86	1.44	0.43	0.00	0.72	0.14
cervical cancer cell line:ME-180	10553-107I4	5966.29	14.58	2.98	3.31	4.81	1.49	1.33	0.99	0.33
cervix, adult, pool1	10013-101C4	3185.19	25.62	8.29	3.78	5.56	2.83	1.26	1.99	0.84
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	3939.10	14.35	2.37	1.67	1.95	1.39	0.84	0.98	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	3176.81	6.53	6.53	1.31	3.92	1.31	1.31	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	1766.33	21.00	2.61	1.37	2.49	2.49	0.75	2.86	0.75
choriocarcinoma cell line:SCH	10785-110H2	3348.79	13.31	4.07	2.34	2.83	1.36	1.36	0.86	0.86
choriocarcinoma cell line:T3M-3	10618-108G6	2206.47	5.69	2.37	0.24	0.71	0.47	0.47	0.24	0.24
chorionic membrane cells, donor1	12238-129G6	2717.56	13.11	8.26	5.70	4.56	2.56	0.57	0.28	0.28
chorionic membrane cells, donor2	12239-129G7	5457.78	45.04	11.04	12.83	8.85	7.66	1.59	2.49	0.80
chorionic membrane cells, donor3	12240-129G8	2730.39	25.83	6.04	3.85	6.04	4.40	1.65	1.65	2.20
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	3776.66	44.43	11.11	12.12	8.08	4.04	2.02	1.01	3.03
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	4909.66	16.52	6.34	5.38	3.84	1.92	1.92	0.96	1.73
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	2083.35	3.17	1.48	0.84	1.69	0.42	0.84	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	1817.64	9.76	0.77	0.26	0.00	0.26	0.26	0.26	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	1799.33	9.43	1.21	0.73	0.73	0.73	0.97	0.48	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	2440.47	18.53	2.24	2.04	1.43	1.02	0.00	0.61	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	1037.96	1.18	0.29	0.88	0.00	0.00	0.00	0.59	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	4635.75	3.65	2.35	1.04	1.04	0.26	0.78	0.00	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	3669.42	56.23	15.77	16.46	7.77	4.80	2.06	5.49	2.51
clear cell carcinoma cell line:TEN	10636-108I6	6903.99	23.77	8.33	6.59	4.34	2.26	1.91	1.56	1.21
colon carcinoma cell line:CACO-2	10513-107D9	2523.23	4.58	2.75	0.73	1.83	1.10	0.55	0.55	0.00
colon carcinoma cell line:COLO-320	10420-106C6	5827.41	15.58	5.70	3.42	2.28	0.76	1.14	0.00	0.76
colon, adult, donor1	10082-102B1	2787.05	21.42	9.52	9.52	4.76	1.19	0.00	2.38	1.19
colon, adult, pool1	10014-101C5	2443.60	21.15	3.06	2.23	8.93	1.65	0.24	2.35	1.18
colon, fetal, donor1	10070-101I7	3529.33	49.44	9.89	9.27	6.80	3.09	0.62	1.85	4.33
common myeloid progenitor CMP, donor1	12130-128D6	3355.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	1852.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	4658.96	7.22	3.82	1.70	1.70	0.85	0.42	0.85	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	6640.99	20.53	5.43	3.47	8.60	2.41	0.60	3.47	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	7822.32	15.37	7.33	2.54	4.09	2.12	2.26	1.13	0.85
corpus callosum, adult, pool1	10042-101F6	2318.49	5.75	1.33	1.55	1.77	0.66	0.77	0.88	0.11
cruciate ligament, donor2	10295-104G7	1875.43	20.26	1.62	2.43	2.43	0.00	0.81	0.00	3.24
diaphragm, fetal, donor1	10069-101I6	1538.51	11.24	5.62	1.61	2.41	4.01	2.41	0.80	0.80
diencephalon, adult	10193-103E4	1508.09	15.36	4.56	2.40	0.48	1.68	0.48	0.48	1.92
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	2264.66	35.36	12.17	5.28	5.05	2.07	1.84	2.76	1.15
ductal cell carcinoma cell line:KLM-1	10438-106E6	3793.77	4.87	1.54	0.51	2.05	0.77	0.00	0.51	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	2361.48	13.96	3.37	1.93	2.89	1.20	0.72	0.72	0.72
ductus deferens, adult	10196-103E7	2389.04	25.42	5.48	2.49	1.99	0.00	3.49	0.50	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	2586.65	27.36	8.64	5.76	2.88	2.88	1.44	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	2821.95	64.74	16.18	10.30	6.62	2.94	5.89	4.41	4.41
dura mater, adult, donor1	10041-101F5	3675.71	14.04	4.21	4.21	3.30	1.98	1.24	1.65	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	2128.12	18.43	3.11	2.00	4.66	2.00	0.67	2.44	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	6170.50	19.77	6.73	2.15	2.58	1.86	0.57	1.15	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	1932.47	3.08	0.00	1.23	0.62	0.62	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	3393.39	18.16	3.94	1.82	2.12	1.51	0.30	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	2698.17	5.56	0.93	0.31	1.85	0.31	0.31	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	2490.33	3.94	3.94	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	3238.33	6.70	0.67	2.35	1.34	0.34	0.34	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	4543.75	11.42	5.44	2.72	2.72	1.99	0.72	1.09	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	3126.37	44.55	15.76	10.13	5.95	2.73	3.38	1.29	1.93
epidermoid carcinoma cell line:A431	10426-106D3	3553.30	6.89	1.33	1.33	1.56	0.22	0.78	0.11	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	3449.58	5.72	3.85	1.76	1.54	0.88	0.44	0.44	0.44
epididymis, adult	10197-103E8	1955.80	35.79	12.35	4.40	6.07	3.35	2.09	1.26	2.72
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	4036.97	11.18	4.97	2.84	3.19	0.71	0.71	0.35	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	2990.60	7.86	1.97	0.79	0.79	0.39	0.39	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	3866.88	36.43	11.66	6.55	2.23	2.62	3.93	2.62	2.36
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	3018.25	23.42	7.28	2.66	1.67	1.28	2.26	1.57	0.59
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	3941.09	33.27	14.90	6.50	3.47	3.25	3.14	3.25	1.57
esophagus, adult, pool1	10015-101C6	3393.66	34.72	9.77	7.64	7.33	3.50	1.27	1.59	1.81
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	3950.82	9.52	1.63	1.50	2.13	0.88	0.13	0.50	0.38
eye - muscle inferior rectus, donor1	10272-104E2	610.89	7.24	2.41	2.41	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	534.47	6.31	2.10	0.00	4.21	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	474.74	1.49	1.49	0.00	1.49	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	999.75	0.00	3.44	2.29	2.29	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	1024.55	14.57	4.37	2.91	4.37	1.46	1.46	0.00	1.46
eye, fetal, donor1	10054-101G9	2608.44	38.14	9.66	9.66	2.29	2.54	2.54	1.78	1.78
fibrosarcoma cell line:HT-1080	10758-110E2	4610.95	13.59	5.90	3.85	4.23	1.41	1.28	1.28	1.03
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	2692.10	11.40	4.99	3.09	4.75	0.95	2.14	0.71	0.71
frontal lobe, adult, pool1	10040-101F4	1836.23	3.94	1.78	0.47	0.84	0.38	0.28	0.47	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	2740.07	7.51	5.10	2.40	0.90	1.20	0.90	1.50	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	3606.98	8.14	2.65	1.74	1.19	0.46	0.91	0.46	0.55
gall bladder, adult	10198-103E9	2429.78	41.28	6.76	6.52	5.55	4.10	0.97	2.17	1.45
gamma delta positive T cells, donor1	11937-126A2	3520.69	15.57	5.37	2.68	4.29	2.15	4.29	1.07	1.07
gamma delta positive T cells, donor2	11938-126A3	3303.53	12.70	6.72	2.99	2.99	0.37	1.12	1.49	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	2266.35	34.22	8.66	6.55	3.80	3.17	1.90	1.06	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	1839.58	7.93	2.32	2.13	0.97	0.97	0.77	0.39	0.39
gastric cancer cell line:AZ521	10549-107H9	3354.20	5.08	1.97	1.31	1.80	0.49	0.82	0.16	0.49
gastric cancer cell line:GSS	10560-108A2	5399.83	34.78	3.66	7.32	7.32	3.66	0.92	1.83	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	2018.65	24.44	6.63	3.43	2.28	2.74	1.37	0.91	0.91
giant cell carcinoma cell line:LU65	10487-107B1	205.61	0.92	0.23	0.00	0.46	0.23	0.11	0.11	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	2365.87	6.30	1.26	0.70	0.70	0.56	0.28	0.14	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	1988.36	4.99	3.24	2.49	2.24	0.25	1.25	0.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	4903.96	6.97	2.85	1.27	1.48	0.95	0.32	0.11	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	4915.21	5.20	1.83	1.26	1.97	0.98	0.70	0.42	0.56
glioblastoma cell line:T98G	10485-107A8	2730.08	5.74	1.66	0.66	1.77	0.88	0.88	0.44	0.44
glioma cell line:GI-1	10413-106B8	3255.92	19.62	6.44	1.46	3.22	0.59	0.00	0.88	0.59
globus pallidus - adult, donor10196	10175-103C4	2005.24	9.48	2.19	1.46	3.64	0.00	0.00	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	1373.03	9.52	4.64	1.46	0.49	0.49	0.73	0.73	0.24
globus pallidus, adult, donor10258	10367-105F7	992.68	20.54	8.22	2.74	5.48	2.74	0.00	2.74	0.00
globus pallidus, newborn, donor10223	10364-105F4	2199.35	19.72	4.26	3.20	2.13	3.20	0.00	0.00	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	7025.74	0.00	2.45	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	3245.73	54.64	10.93	0.00	0.00	0.00	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	4860.72	10.45	5.23	5.23	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	6374.95	32.32	8.00	4.80	5.76	2.24	1.28	0.32	1.92
hIPS +CCl2, biol_rep1	14383-156B9	6282.52	31.22	2.30	5.05	1.84	2.75	0.92	0.92	0.92
hIPS +CCl2, biol_rep2	14384-156C1	7275.50	36.12	1.83	4.57	0.91	0.46	0.00	0.00	0.91
hIPS +CCl2, biol_rep3	14385-156C2	8456.94	34.14	1.29	5.15	0.64	0.64	0.64	0.00	0.00
hIPS, biol_rep1	14380-156B6	8553.30	14.37	1.44	5.75	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	6224.93	24.01	3.43	8.23	0.69	0.00	0.00	0.00	0.69
hIPS, biol_rep3	14382-156B8	2561.15	17.66	1.10	6.62	0.00	0.00	1.10	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	2505.35	11.78	3.16	2.87	4.02	0.29	0.57	0.57	0.57
heart - mitral valve, adult	10205-103F7	1813.24	16.14	4.48	1.20	4.19	2.69	2.09	0.60	0.30
heart - pulmonic valve, adult	10206-103F8	963.28	7.58	1.83	0.78	0.52	0.26	1.31	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	1483.77	23.31	2.50	2.50	4.16	0.83	0.83	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	2136.06	20.41	6.33	5.31	3.06	2.65	2.24	1.43	1.02
heart, adult, diseased, donor1	10051-101G6	674.94	10.22	4.26	1.28	0.43	0.00	0.00	1.28	0.85
heart, adult, pool1	10016-101C7	740.53	2.07	0.23	1.15	0.69	0.00	0.00	0.00	0.23
heart, fetal, pool1	10046-101G1	1722.76	2.77	1.23	0.51	0.72	0.31	0.51	0.51	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	7221.00	18.51	8.95	8.33	6.17	3.09	2.78	0.31	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	2990.78	9.51	4.76	0.00	2.38	2.38	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	4978.61	30.72	10.83	4.20	3.87	2.76	1.44	1.22	1.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	4897.56	45.52	14.08	5.70	4.37	3.16	2.67	2.67	2.06
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	5110.56	34.26	9.30	3.94	2.83	2.22	2.32	1.11	1.11
hepatoma cell line:Li-7	10484-107A7	896.29	2.56	1.45	0.33	0.67	0.33	0.11	0.22	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	4328.05	7.44	4.72	1.81	3.02	1.21	0.80	1.11	0.30
hippocampus - adult, donor10196	10169-103B7	1849.12	12.30	3.79	1.89	1.89	0.00	3.79	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	1248.89	11.84	3.67	2.04	2.04	0.20	0.41	0.82	0.61
hippocampus, adult, donor10258	10374-105G5	2286.59	7.97	0.00	3.98	0.50	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	1559.01	16.57	3.88	2.11	2.47	1.76	0.00	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	6699.13	99.49	22.58	14.65	13.43	6.71	6.10	12.21	7.32
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	5658.36	54.78	9.62	6.09	6.28	7.85	5.30	2.36	3.53
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	6203.17	61.19	10.92	11.93	6.86	6.86	3.05	4.57	2.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	5073.65	122.36	15.79	27.07	9.02	18.61	0.00	6.77	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	5428.12	240.91	35.63	29.44	25.30	36.15	7.23	25.05	5.68
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	6595.34	177.28	18.22	23.16	12.91	23.92	1.52	7.21	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	4495.50	94.59	13.72	26.86	17.81	14.60	5.55	16.64	4.67
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	4599.40	112.45	25.85	24.34	30.38	26.71	4.31	17.88	3.45
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	4482.29	61.73	13.35	21.27	14.18	10.43	1.67	6.67	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	8136.44	50.20	11.60	21.07	11.13	9.95	4.50	4.74	1.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	8195.12	123.75	34.07	29.41	27.00	23.95	6.59	16.07	4.66
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	7645.35	32.32	8.75	6.06	9.43	7.41	1.35	10.10	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	5081.21	59.46	16.43	15.65	10.17	9.70	4.69	6.73	3.76
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	5522.64	110.05	21.62	31.93	7.86	11.30	5.40	14.74	5.90
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	6506.38	61.09	11.35	13.96	6.98	4.36	1.75	7.85	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	6016.74	152.16	20.81	26.73	24.05	30.74	4.39	12.41	2.86
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	6266.80	134.31	15.70	29.65	12.65	25.29	3.49	10.90	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	5567.34	172.42	22.49	23.99	14.49	22.99	4.00	13.49	3.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	4633.11	113.79	21.48	29.39	24.87	26.37	5.84	22.80	3.39
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	5375.67	126.87	16.82	34.10	14.55	23.19	4.55	20.46	2.27
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	4914.67	88.96	13.16	26.94	12.53	12.22	4.70	14.10	3.13
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	7487.55	132.44	27.11	33.48	18.78	30.21	7.19	27.43	3.59
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	8281.65	161.99	27.00	56.90	17.13	27.87	9.87	20.90	2.90
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	6946.67	137.21	19.13	37.66	15.25	17.94	3.29	17.64	4.78
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	5453.29	63.18	15.70	8.68	8.31	11.64	5.73	6.47	1.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	5752.76	52.21	8.27	16.26	8.56	8.56	2.28	3.71	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	6812.68	69.00	16.33	18.78	7.35	11.02	4.08	6.94	3.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	6327.24	173.93	26.41	35.91	23.59	24.65	4.93	13.73	8.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	5592.68	132.08	20.59	25.34	20.59	25.02	4.75	10.77	2.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	6543.26	137.39	20.58	33.59	20.88	25.42	3.63	13.32	2.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	4406.92	77.05	13.45	19.65	9.83	12.41	4.14	13.96	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	4465.86	61.77	10.63	15.28	17.93	13.28	1.99	9.96	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	4149.93	48.23	13.08	11.80	8.98	8.47	2.82	9.49	2.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	7832.55	163.36	35.02	36.81	22.24	24.29	6.14	20.45	5.88
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	7119.41	86.32	18.93	17.42	18.93	11.36	0.00	10.60	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	8234.41	105.19	14.79	18.15	16.47	16.13	3.36	17.81	5.38
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	6051.18	67.38	11.11	10.87	8.69	14.97	4.59	6.76	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	6565.45	81.11	10.25	14.26	4.46	9.36	3.12	6.68	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	6228.35	63.42	11.71	13.17	7.32	7.32	3.90	3.90	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	6382.83	173.90	11.00	16.50	15.89	17.73	3.06	8.56	3.06
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	4154.39	162.66	32.53	22.77	6.51	32.53	13.01	19.52	19.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	7015.65	181.03	24.16	36.07	17.87	31.44	8.27	12.58	3.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	5904.81	125.88	18.61	12.04	12.59	13.14	2.74	10.40	3.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	5408.72	93.37	16.28	28.95	14.48	18.09	2.53	10.49	3.26
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	5207.47	121.00	9.96	20.28	15.30	21.00	2.85	11.03	3.56
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	9779.78	128.89	15.51	10.74	8.35	8.35	2.39	4.77	5.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	10550.46	178.22	21.13	34.67	16.12	25.87	2.17	16.25	2.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	8090.20	108.03	16.16	24.51	11.58	15.36	5.39	9.43	1.35
immature langerhans cells, donor1	11904-125F5	2530.19	9.20	0.73	1.21	1.70	0.48	0.97	0.00	0.24
immature langerhans cells, donor2	11905-125F6	3970.17	25.35	3.17	0.79	1.58	3.17	2.38	0.00	2.38
insula, adult, pool1	10039-101F3	2179.60	3.60	1.80	0.47	1.14	0.85	0.66	0.38	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	1148.75	4.88	1.95	2.60	0.98	0.33	0.98	1.30	0.65
kidney, adult, pool1	10017-101C8	2044.30	12.62	4.61	2.10	5.81	1.60	1.00	0.90	0.70
kidney, fetal, pool1	10045-101F9	4754.44	10.96	5.45	2.48	2.41	1.70	1.27	1.34	0.42
large cell lung carcinoma cell line:IA-LM	10509-107D5	2873.08	7.67	1.28	0.14	1.14	0.85	0.71	0.00	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	1138.70	16.04	3.04	2.35	1.24	0.97	2.07	0.28	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	1864.36	2.57	1.10	0.92	0.18	0.73	0.55	0.18	0.18
left atrium, adult, donor1	10079-102A7	994.90	15.80	4.36	0.54	2.18	1.09	0.54	1.09	0.54
left ventricle, adult, donor1	10078-102A6	778.20	12.64	3.54	3.03	1.01	0.51	1.52	1.01	0.51
leiomyoblastoma cell line:G-402	10721-110A1	6051.16	9.03	7.39	2.74	4.38	2.46	3.56	1.09	1.92
leiomyoma cell line:10964C	10569-108B2	2911.35	61.43	18.68	15.09	7.90	11.50	2.51	3.95	2.87
leiomyoma cell line:15242A	10570-108B3	5269.05	64.67	15.76	15.76	12.50	4.35	5.43	4.89	3.26
leiomyoma cell line:15425	10571-108B4	3773.11	89.84	22.58	21.85	8.50	8.74	5.34	6.31	3.64
leiomyosarcoma cell line:Hs 5.T	10722-110A2	2863.57	12.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	3483.78	21.96	5.23	0.00	3.14	2.09	0.00	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	4353.86	9.09	4.60	2.36	2.72	2.01	0.71	0.94	0.24
liposarcoma cell line:KMLS-1	10782-110G8	4977.01	32.65	8.44	7.34	5.94	1.87	1.72	2.50	1.25
liposarcoma cell line:SW 872	10726-110A6	3048.54	7.92	3.41	1.95	2.56	1.83	0.49	0.73	0.24
liver, adult, pool1	10018-101C9	1882.34	23.66	2.43	1.62	3.40	2.11	0.81	0.65	0.81
liver, fetal, pool1	10086-102B5	1787.35	16.93	8.47	8.47	1.88	0.94	3.76	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	1959.59	8.75	2.77	1.75	2.62	1.46	0.29	0.58	0.44
locus coeruleus, adult, donor10252	10165-103B3	1295.55	12.18	4.24	2.40	1.11	0.55	1.48	0.74	0.55
locus coeruleus, adult, donor10258	10375-105G6	2013.34	37.24	11.57	11.00	5.08	5.36	4.80	5.08	4.23
locus coeruleus, newborn, donor10223	10362-105F2	2660.83	23.13	6.73	2.10	4.63	2.94	0.00	1.68	2.10
lung adenocarcinoma cell line:A549	10499-107C4	4676.22	7.06	2.21	0.83	1.66	0.83	0.55	0.28	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	3791.04	0.00	2.07	0.69	0.69	1.38	0.00	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	8305.87	20.17	8.30	9.10	8.83	5.40	7.65	4.09	1.71
lung, adult, pool1	10019-101D1	3132.86	28.59	6.02	3.43	8.27	2.48	2.13	2.13	1.30
lung, fetal, donor1	10068-101I5	4279.68	14.84	3.42	1.71	3.71	1.14	0.29	0.00	0.57
lung, right lower lobe, adult, donor1	10075-102A3	1661.03	32.08	13.75	5.96	5.50	2.29	4.58	2.29	0.46
lymph node, adult, donor1	10077-102A5	2636.63	47.81	11.36	5.21	4.26	4.73	3.31	2.37	0.00
lymphangiectasia cell line:DS-1	10727-110A7	372.16	0.66	0.22	1.10	1.10	0.00	0.66	0.44	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	2879.53	14.34	8.60	3.77	5.13	0.91	1.21	0.45	1.66
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	2320.82	11.04	0.00	1.70	1.70	0.85	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	1027.84	3.55	0.00	0.44	1.33	0.44	0.00	0.00	0.44
mature adipocyte, donor2	12232-129F9	988.46	5.19	1.87	0.21	0.21	0.21	0.00	0.21	0.21
mature adipocyte, donor3	12233-129G1	616.60	2.84	0.24	0.24	0.24	0.00	0.24	0.00	0.00
mature adipocyte, donor4	12234-129G2	1198.17	3.42	0.79	0.79	0.00	0.53	0.26	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	3402.10	17.15	1.43	0.95	0.48	1.91	0.48	0.71	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	1627.75	10.15	4.51	1.13	1.13	1.13	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	1024.17	8.64	3.31	1.29	1.47	0.37	0.74	0.92	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	1295.21	9.21	2.54	2.86	0.32	0.00	0.32	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	1455.60	26.02	11.09	2.56	2.56	0.00	0.85	0.85	2.13
medial temporal gyrus - adult, donor10196	10183-103D3	1637.05	33.92	9.79	4.56	4.89	1.69	2.03	2.87	1.52
medial temporal gyrus, adult, donor10252	10156-103A3	1035.02	7.22	3.61	2.76	1.06	0.64	0.00	0.42	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	2454.05	1.93	1.93	0.00	0.00	0.00	0.00	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	473.67	0.00	14.35	0.00	0.00	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	1924.59	12.56	6.10	1.08	4.31	1.44	1.44	1.44	0.72
medulla oblongata - adult, donor10196	10174-103C3	2015.73	15.58	2.60	2.60	1.30	0.00	0.00	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	1315.37	10.99	3.56	1.70	1.70	1.08	0.46	1.55	0.31
medulla oblongata, adult, pool1	10038-101F2	2513.14	4.24	1.63	0.33	0.98	0.24	0.49	0.41	0.65
medulla oblongata, newborn, donor10223	10361-105F1	2291.39	21.87	3.12	3.12	2.78	1.39	0.69	1.39	1.74
medulloblastoma cell line:D283 Med	10838-111E1	8595.65	127.98	25.68	8.19	5.54	3.99	8.64	3.32	4.21
medulloblastoma cell line:ONS-76	10759-110E3	5474.88	7.70	5.01	2.45	3.91	1.10	1.22	0.61	0.86
melanoma cell line:COLO 679	10514-107E1	3598.26	23.29	2.44	5.03	3.16	3.16	0.43	2.16	1.29
melanoma cell line:G-361	10465-106H6	3959.28	39.90	4.89	2.17	6.52	2.99	0.27	2.99	0.27
meningioma cell line:HKBMM	10691-109F7	2124.36	32.74	8.68	10.31	3.98	2.53	1.45	1.09	1.81
merkel cell carcinoma cell line:MKL-1	10843-111E6	2450.50	28.20	8.81	7.93	6.17	3.52	2.64	2.64	5.29
merkel cell carcinoma cell line:MS-1	10844-111E7	4880.40	41.99	15.03	8.55	5.44	2.85	1.81	1.30	1.81
mesenchymal precursor cell - adipose, donor1	11747-123G1	5308.82	45.11	10.13	10.43	4.45	3.84	5.06	2.76	1.07
mesenchymal precursor cell - adipose, donor2	11748-123G2	3168.08	30.54	4.36	6.00	3.82	1.45	2.00	1.64	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	5290.58	38.51	6.21	4.97	2.48	1.66	2.90	0.41	1.66
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	3127.82	22.05	3.93	6.18	3.37	2.25	2.81	1.69	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	3954.78	35.82	6.74	10.59	5.01	2.89	3.66	1.35	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	2457.04	22.21	7.63	2.08	2.78	0.69	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	2056.87	20.08	3.43	6.87	1.89	2.57	1.37	0.86	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	2949.92	29.90	5.29	7.71	3.45	3.91	2.30	1.96	1.27
mesenchymal precursor cell - cardiac, donor3	11754-123G8	3564.89	29.45	5.57	7.96	3.18	1.99	3.58	1.59	1.46
mesenchymal precursor cell - cardiac, donor4	11755-123G9	4066.20	31.73	5.27	6.62	3.24	3.11	2.30	1.89	1.08
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	3673.36	30.44	5.12	7.97	4.55	3.56	2.99	1.85	1.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	1876.33	18.11	4.61	1.65	1.65	0.99	0.33	0.66	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	6186.47	29.89	4.01	8.44	2.77	2.63	2.49	2.63	1.66
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	5717.28	34.21	10.12	3.14	4.19	1.40	0.35	0.35	2.09
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	4403.43	37.36	6.74	14.29	6.12	4.90	3.88	2.25	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	3688.72	31.63	10.06	5.03	5.75	2.52	0.72	0.36	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	7616.80	50.69	7.76	14.69	4.97	4.34	4.24	3.00	2.79
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	3321.38	39.21	10.03	6.61	9.80	2.05	1.14	0.68	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	4252.63	44.47	8.81	7.13	5.45	1.26	4.20	4.20	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	4135.54	39.45	6.28	17.04	3.59	4.48	4.48	2.69	1.49
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	5480.46	40.53	7.00	11.38	4.11	3.33	4.64	1.75	1.31
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	6394.93	46.76	13.25	4.05	3.68	1.10	3.31	0.00	2.58
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	4395.38	48.07	16.02	5.15	9.73	2.86	1.72	1.43	1.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	6706.34	106.10	32.00	24.00	10.95	7.16	4.21	6.32	8.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	6000.19	43.38	7.31	14.16	9.13	5.48	3.20	1.83	2.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	6032.16	52.69	11.51	12.02	6.14	3.84	2.05	3.07	2.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	6505.44	40.31	8.38	7.59	6.54	2.09	1.31	0.79	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	6360.76	65.93	15.10	8.32	5.24	2.77	3.70	2.77	2.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	5758.19	78.37	14.59	6.35	5.41	3.29	4.47	3.06	3.06
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	6220.83	63.97	12.18	10.49	4.74	2.03	2.71	2.71	4.74
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	6046.27	55.02	8.65	4.32	4.72	2.75	2.36	0.79	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	5716.32	68.12	12.97	6.02	5.10	2.78	3.24	1.39	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	6424.38	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	7465.39	65.76	8.36	9.23	8.08	6.35	2.60	2.31	1.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	6547.55	37.93	6.25	5.58	6.02	1.78	2.01	2.01	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	6468.10	45.67	9.61	6.97	6.01	5.77	3.36	1.92	1.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	7067.08	40.33	10.27	9.53	5.13	2.20	2.93	0.73	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	5918.30	43.97	5.37	6.04	4.36	4.03	2.01	3.02	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	6218.87	45.85	7.78	4.09	5.32	2.05	2.87	1.64	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	5964.84	58.85	7.30	6.87	2.15	1.72	2.15	1.72	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	6718.45	57.42	16.41	2.73	5.47	2.73	0.00	0.00	8.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5919.09	113.63	25.82	10.33	15.49	5.16	0.00	5.16	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	6046.54	73.08	19.81	9.74	10.07	2.60	0.32	2.60	2.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	6154.60	75.66	17.46	17.46	8.73	7.27	7.27	2.91	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	6097.90	85.83	22.39	12.79	15.46	5.33	3.73	2.13	3.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	5453.71	63.79	12.27	7.36	8.18	1.64	4.09	0.82	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	5261.72	59.09	17.49	9.72	7.39	3.50	1.17	1.94	2.33
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	5458.79	71.36	14.69	10.49	10.49	0.00	4.20	2.10	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	4867.99	72.52	14.90	2.98	7.95	3.97	0.00	0.99	3.97
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	5649.16	52.44	14.30	9.53	4.77	0.00	19.07	4.77	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	4935.25	73.53	12.45	10.08	6.52	5.93	0.59	2.96	3.56
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	5746.25	77.98	14.62	4.87	6.09	6.09	2.44	1.22	6.09
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	5897.44	135.26	0.00	0.00	0.00	0.00	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	5387.55	59.54	13.30	10.13	6.33	2.53	4.43	1.27	3.17
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	2984.11	32.42	6.90	5.86	4.83	2.07	1.72	1.38	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	3535.44	45.13	4.30	2.15	6.45	2.15	2.15	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3636.53	47.90	3.99	3.99	7.98	3.99	0.00	3.99	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	2272.96	44.77	3.44	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	2089.91	25.26	3.26	4.07	1.63	1.22	0.81	1.22	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	2212.52	30.98	3.97	6.36	3.97	1.59	3.97	1.59	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	1241.54	9.43	0.00	0.59	2.36	0.59	1.77	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	1235.91	5.92	1.25	2.18	1.25	0.31	0.62	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	1275.19	16.04	4.01	6.68	1.34	0.00	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	1846.15	29.57	1.18	2.37	1.18	2.37	1.18	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	2272.68	38.52	0.00	7.70	2.57	7.70	2.57	5.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	2251.06	19.96	3.44	2.75	2.07	2.75	1.38	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	1222.67	9.90	0.99	3.96	0.49	0.00	0.49	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	1166.37	15.70	3.36	7.85	1.12	1.12	3.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	1240.32	14.63	1.91	1.91	0.00	0.00	0.00	0.64	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	1077.98	8.46	2.82	0.00	0.81	1.21	0.40	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	1247.30	15.26	0.00	4.36	0.00	2.18	2.18	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1094.74	13.94	1.27	2.53	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	344.11	4.86	0.61	1.21	0.61	0.61	0.00	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	551.31	4.52	0.00	0.00	0.00	0.00	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	426.67	2.47	1.65	1.65	0.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	1539.98	2.58	2.18	1.39	0.79	0.79	0.00	0.60	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	1513.44	16.55	2.27	5.84	0.97	2.60	1.62	1.30	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	1703.15	15.28	5.09	7.13	2.04	1.02	1.02	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	3818.28	2.32	0.77	2.32	0.77	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	6669.33	11.81	2.83	1.89	2.13	0.47	0.24	0.71	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	2781.71	7.18	0.70	0.70	1.39	0.93	1.16	0.23	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	4320.60	34.19	8.55	4.27	0.00	8.55	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	6191.32	18.91	5.55	2.67	4.32	1.95	1.03	1.54	0.72
mesothelioma cell line:Mero-25	10850-111F4	4180.49	41.76	11.57	4.54	6.13	3.18	2.50	1.36	1.82
mesothelioma cell line:Mero-41	10851-111F5	7083.18	64.54	13.45	7.82	7.09	3.42	3.42	2.44	3.18
mesothelioma cell line:Mero-48a	10852-111F6	7689.63	47.61	11.96	7.09	9.96	3.76	3.54	2.21	1.99
mesothelioma cell line:Mero-82	10853-111F7	3518.96	19.45	5.52	3.68	3.94	2.10	0.53	1.31	0.79
mesothelioma cell line:Mero-83	10854-111F8	6527.62	48.85	10.38	6.13	4.60	4.43	3.57	3.40	2.21
mesothelioma cell line:Mero-84	10855-111F9	6754.88	40.44	10.87	4.80	6.82	2.27	3.03	1.26	3.03
mesothelioma cell line:Mero-95	10856-111G1	2407.70	24.02	5.80	2.28	2.90	1.86	2.28	0.41	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	6993.81	50.36	7.45	4.14	6.96	2.48	3.64	0.99	2.32
mesothelioma cell line:NCI-H226	10846-111E9	3660.02	25.34	6.15	3.80	5.43	1.99	2.35	1.81	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	1783.56	12.64	3.25	2.05	1.54	0.34	1.02	0.51	0.68
mesothelioma cell line:NCI-H28	10845-111E8	4977.35	55.22	14.00	5.85	4.58	3.56	3.05	2.54	3.56
mesothelioma cell line:No36	10857-111G2	2505.56	21.53	4.57	2.28	2.28	1.63	1.30	0.65	0.65
mesothelioma cell line:ONE58	10858-111G3	3266.33	21.95	9.48	4.06	7.32	2.71	1.90	1.90	0.27
migratory langerhans cells, donor1	11901-125F2	7283.27	41.84	10.75	4.22	5.37	2.69	2.69	1.15	3.84
migratory langerhans cells, donor2	11902-125F3	6664.82	33.34	7.33	3.42	4.88	2.44	2.32	0.73	3.42
migratory langerhans cells, donor3	11903-125F4	10588.81	34.64	7.90	3.77	3.77	2.15	1.62	0.54	1.44
mixed mullerian tumor cell line:HTMMT	10689-109F5	615.41	13.71	2.61	3.26	2.29	2.29	1.63	0.33	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	2268.56	33.06	12.50	11.87	4.45	3.39	1.06	1.91	2.12
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	7291.74	8.75	5.99	1.38	4.61	0.23	1.15	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	8552.87	33.11	11.04	8.56	8.37	5.90	3.04	2.28	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	6524.09	20.51	8.32	2.96	2.77	1.85	1.48	0.37	1.11
myeloma cell line:PCM6	10474-106I6	2101.99	4.94	3.36	2.57	0.99	0.59	0.40	0.99	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	2860.10	8.12	4.57	1.01	4.06	0.51	3.04	0.00	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	6745.24	12.55	3.53	4.12	2.35	1.96	0.20	0.78	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	2468.28	6.24	3.34	1.67	1.78	1.23	0.89	1.11	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	2570.54	8.82	3.31	1.62	1.47	1.54	1.32	1.25	0.51
nasal epithelial cells, donor2	12227-129F4	3057.47	9.38	2.76	0.55	2.76	0.00	0.55	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	5953.97	9.43	2.99	1.61	2.07	0.92	1.15	0.46	0.46
neuroblastoma cell line:NB-1	10539-107G8	5159.07	7.48	2.06	2.06	2.62	1.12	0.75	1.12	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	2052.37	9.28	3.16	2.32	1.48	0.63	0.00	1.05	0.42
neuroblastoma cell line:NH-12	10555-107I6	5491.39	9.88	2.98	2.05	1.30	1.30	0.56	0.75	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	7651.00	93.70	19.69	9.25	13.52	5.22	4.98	4.03	3.56
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	3328.84	31.68	15.05	9.82	5.54	3.64	1.43	1.43	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	2823.88	6.84	5.23	3.82	1.61	1.61	1.41	0.60	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	4649.36	4.45	2.54	0.64	1.91	0.64	0.00	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	11372.23	21.03	13.31	7.72	8.78	2.40	2.40	0.80	1.60
neutrophil PMN, donor1	12133-128D9	7958.02	14.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	2948.31	0.00	0.00	13.28	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	6743.09	28.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	2982.27	9.47	3.55	1.18	2.37	1.18	1.18	0.68	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	4415.60	7.20	3.20	0.80	2.40	3.20	0.00	0.00	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	6076.13	42.32	14.43	12.82	13.79	7.69	4.49	6.09	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	4613.88	81.19	21.02	17.87	8.93	6.57	3.68	4.99	4.20
nucleus accumbens, adult, pool1	10037-101F1	2117.47	3.84	1.69	1.12	1.03	0.47	0.37	0.56	0.47
occipital cortex - adult, donor10196	10172-103C1	1623.58	28.85	6.18	2.06	2.06	2.06	0.00	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	917.80	5.90	2.68	1.07	0.81	0.81	0.00	1.07	0.54
occipital cortex, newborn, donor10223	10355-105E4	1906.34	20.02	5.46	2.55	4.37	0.36	0.00	1.46	0.36
occipital lobe, adult, donor1	10076-102A4	1540.28	18.37	14.69	2.89	12.07	4.46	0.79	1.31	1.31
occipital lobe, fetal, donor1	10073-102A1	6663.07	48.06	45.48	14.16	18.88	3.43	3.86	4.29	1.72
occipital pole, adult, pool1	10036-101E9	1899.92	3.15	0.79	1.10	0.63	0.47	0.39	0.32	0.16
olfactory region, adult	10195-103E6	1894.66	20.25	5.16	2.48	1.34	0.57	0.57	0.00	0.57
optic nerve, donor1	10277-104E7	1286.67	14.01	4.00	2.00	8.00	0.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	5388.76	22.55	4.21	3.42	4.21	4.21	0.68	1.82	1.03
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	5346.81	6.05	3.57	0.55	1.65	1.24	0.96	0.55	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	4064.45	68.24	14.22	5.25	5.59	2.03	1.02	1.35	2.20
oral squamous cell carcinoma cell line:SAS	10544-107H4	3526.48	14.21	2.77	2.77	1.50	1.27	1.16	0.58	0.92
osteoclastoma cell line:Hs 706.T	10704-109H2	4403.92	26.16	5.00	6.17	4.70	0.88	0.59	1.47	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	3881.23	1.87	0.00	0.00	0.93	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	2191.84	2.54	1.48	1.48	1.70	0.42	0.21	0.64	0.00
ovary, adult, pool1	10020-101D2	5826.70	39.92	6.64	5.50	3.49	2.97	1.31	1.83	0.79
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	5010.33	13.93	7.88	4.03	5.13	2.02	1.47	0.92	0.92
pancreas, adult, donor1	10049-101G4	3602.65	50.79	13.17	3.76	2.82	5.64	2.82	1.88	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	2409.59	13.42	2.80	2.24	4.47	1.12	0.28	1.12	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	2623.27	42.59	15.84	5.45	4.94	2.56	1.53	1.36	3.07
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	6655.42	19.54	2.98	2.48	3.31	1.66	1.32	0.17	1.16
paracentral gyrus, adult, pool1	10035-101E8	1840.33	3.94	1.28	0.82	1.10	0.55	0.64	0.37	0.18
parietal cortex, adult, donor10258	10373-105G4	1718.31	5.14	2.20	0.00	0.73	0.73	0.00	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	1434.24	15.99	1.88	0.94	4.70	0.00	0.00	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	903.57	11.97	2.28	1.71	0.00	0.86	0.57	0.57	0.29
parietal lobe, adult, pool1	10034-101E7	1695.95	3.08	1.50	0.62	0.97	0.26	0.44	0.44	0.09
parietal lobe, fetal, donor1	10072-101I9	5225.47	59.16	32.97	14.55	12.61	3.88	8.73	8.73	3.88
parietal lobe, newborn, donor10223	10356-105E5	2163.90	13.09	3.74	0.37	6.36	0.37	1.50	0.75	1.50
parotid gland, adult	10199-103F1	1462.73	15.42	6.78	1.85	0.00	1.85	1.23	0.62	0.62
penis, adult	10200-103F2	1361.04	25.24	3.76	2.15	1.07	3.76	2.69	1.61	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	5004.66	44.62	9.11	10.97	6.69	3.72	3.90	2.23	2.60
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	2431.65	8.89	3.06	2.48	3.06	1.17	1.17	0.87	0.44
pineal gland - adult, donor10196	10179-103C8	2264.05	11.61	3.87	1.29	0.65	1.29	0.00	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	1745.84	4.15	1.18	1.18	1.78	0.59	0.59	1.18	0.59
pineal gland, adult, donor10258	10377-105G8	1178.90	8.15	3.14	0.63	0.63	0.63	1.88	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	2865.42	26.31	9.11	2.02	2.02	2.02	2.02	2.02	3.04
pituitary gland, adult, donor10252	10162-103A9	2481.34	7.30	1.56	1.56	1.56	0.00	0.00	1.04	0.00
pituitary gland, adult, donor10258	10378-105G9	1366.24	7.66	1.70	2.55	2.55	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	2734.76	12.69	4.95	3.87	2.80	1.72	0.97	0.43	0.86
plasma cell leukemia cell line:ARH-77	10840-111E3	2813.14	23.04	3.84	3.05	1.59	0.93	1.46	0.93	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	3995.88	17.59	5.91	2.33	2.80	2.02	1.25	0.47	0.93
pons, adult, pool1	10033-101E6	1679.09	3.53	0.86	0.86	0.86	0.09	0.09	0.34	0.34
postcentral gyrus, adult, pool1	10032-101E5	1887.87	5.49	2.96	2.79	1.13	1.22	0.61	0.61	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	4661.72	2.09	0.00	0.00	0.00	0.00	2.09	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	2065.51	0.00	0.00	0.00	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	2499.72	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	3188.68	13.98	6.70	2.62	3.79	1.17	1.46	0.73	0.58
prostate cancer cell line:PC-3	10439-106E7	3590.83	5.08	2.72	0.91	2.18	0.00	0.54	0.54	0.54
prostate, adult, pool1	10022-101D4	2389.82	16.96	2.90	2.90	2.36	3.08	1.00	0.91	0.36
putamen, adult, donor10196	10176-103C5	2350.96	20.77	7.32	3.30	2.60	2.36	0.94	0.94	2.12
putamen, adult, donor10252	10152-102I8	1162.71	7.84	3.92	1.96	3.92	0.00	0.00	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	5206.15	14.21	0.00	2.19	0.00	0.00	0.00	0.00	3.28
putamen, adult, donor10258, tech_rep2	10372-105G3	2116.76	8.94	3.14	1.69	0.97	0.97	0.97	0.00	0.24
putamen, newborn, donor10223	10365-105F5	3294.76	20.24	9.00	2.25	5.25	1.50	0.00	1.50	0.75
rectal cancer cell line:TT1TKB	10469-106I1	5118.13	5.53	0.87	1.16	2.04	0.58	0.00	0.29	0.87
rectum, fetal, donor1	10067-101I4	5572.31	34.77	18.08	16.69	8.35	1.39	1.39	1.39	6.95
renal cell carcinoma cell line:OS-RC-2	10411-106B6	2366.75	7.84	2.54	1.27	2.12	0.64	0.42	0.21	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	276.28	0.83	0.00	0.00	0.41	0.00	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	2724.24	9.05	2.78	3.08	0.80	0.89	0.60	0.60	0.80
retinoblastoma cell line:Y79	10475-106I7	3237.92	10.91	7.01	2.08	2.86	0.52	1.56	0.52	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	2032.83	4.06	3.44	1.48	2.83	0.86	1.35	0.74	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	9049.87	5.34	1.41	3.09	1.12	0.56	0.56	0.00	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	5934.76	3.79	8.34	2.27	3.03	0.76	1.52	0.00	0.76
salivary acinar cells, donor1	11771-123I7	4185.29	45.32	6.15	5.50	2.59	3.08	1.78	0.97	1.78
salivary acinar cells, donor2	11772-123I8	2341.10	39.93	4.13	3.44	1.38	2.34	1.79	2.48	1.24
salivary acinar cells, donor3	11773-123I9	2842.85	9.93	2.65	1.32	0.66	0.66	0.66	0.00	0.66
salivary gland, adult, pool1	10093-102C3	2452.53	8.58	0.57	0.57	0.57	0.57	0.57	0.57	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	3059.58	8.26	2.36	1.18	2.53	1.52	0.42	0.67	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	2706.63	6.23	1.41	0.94	2.12	1.53	0.94	0.24	0.12
seminal vesicle, adult	10201-103F3	1942.75	41.80	9.52	4.76	7.41	2.65	5.29	3.70	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	6650.55	97.66	24.54	17.00	9.72	4.86	5.10	4.13	5.83
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	4663.25	54.60	17.61	7.80	10.57	1.76	1.76	1.26	2.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	6845.10	69.24	13.05	7.02	7.02	0.00	2.01	0.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	5639.32	18.00	5.24	4.16	3.36	0.94	2.28	1.34	1.07
signet ring carcinoma cell line:Kato III	10436-106E4	1780.82	4.09	1.33	0.55	1.55	0.44	0.33	0.66	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	3440.97	13.81	1.94	2.19	1.94	1.16	0.13	0.65	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	314.94	3.55	0.71	0.71	0.00	0.71	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	1398.35	10.79	2.52	2.04	3.36	1.08	0.72	0.60	0.60
skeletal muscle, fetal, donor1	10066-101I3	2567.82	26.13	12.06	8.04	19.10	1.01	2.01	1.01	0.00
skin, adult, donor1	10074-102A2	3684.37	88.21	13.57	0.00	0.00	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	1917.04	20.20	28.41	3.79	20.83	3.16	1.89	1.89	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	5470.78	16.34	8.67	5.67	6.67	1.00	3.00	0.67	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	3307.76	45.39	16.08	6.30	5.04	0.95	2.21	2.84	2.21
small cell lung carcinoma cell line:DMS 144	10841-111E4	2641.61	35.08	5.78	3.85	2.70	0.96	1.16	0.58	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	4623.07	10.55	2.80	1.15	0.99	1.81	0.82	0.82	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	3346.32	43.27	5.79	1.93	2.25	0.97	2.57	1.29	1.93
small cell lung carcinoma cell line:WA-hT	10562-108A4	1591.89	5.23	2.18	0.44	0.65	0.65	0.87	0.22	0.00
small intestine, adult, pool1	10024-101D6	3456.80	30.46	8.12	4.30	14.69	8.84	1.19	2.63	0.96
small intestine, fetal, donor1	10064-101I1	3976.84	48.40	17.44	7.86	7.37	3.19	2.46	2.46	1.97
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	1831.06	33.34	13.34	3.08	3.59	3.08	1.03	0.00	3.08
smooth muscle, adult, pool1	10048-101G3	1254.80	10.60	3.88	4.14	1.55	0.78	0.26	1.03	0.26
somatostatinoma cell line:QGP-1	10781-110G7	9257.98	10.99	7.24	4.56	7.24	1.61	2.41	0.54	1.07
spinal cord - adult, donor10196	10181-103D1	1744.63	19.73	6.65	3.90	4.36	1.84	0.92	2.06	0.46
spinal cord, adult, donor10252	10159-103A6	1528.59	7.89	3.55	0.00	2.37	0.39	1.18	0.39	0.39
spinal cord, adult, donor10258	10369-105F9	2640.59	15.22	3.46	0.69	1.38	0.00	0.69	2.08	0.69
spinal cord, fetal, donor1	10056-101H2	3135.16	40.86	27.44	7.93	14.03	1.83	3.66	3.66	3.05
spinal cord, newborn, donor10223	10359-105E8	2064.16	32.60	9.18	3.21	2.30	0.92	1.84	0.46	4.59
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	11174.99	16.73	10.01	6.12	6.12	3.73	3.73	1.49	0.90
spleen, adult, pool1	10025-101D7	2613.71	19.82	4.30	2.64	2.53	2.31	0.99	0.88	0.77
spleen, fetal, pool1	10044-101F8	3405.92	11.44	2.38	2.54	2.22	0.87	0.72	0.40	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	6221.09	11.70	4.14	4.45	2.79	1.55	1.24	0.52	0.72
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	2210.54	3.99	1.33	0.57	0.95	0.38	0.57	0.57	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	4074.26	51.72	10.48	9.09	5.59	2.10	4.54	2.80	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	2484.76	20.33	5.08	1.56	0.78	1.17	0.39	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	1502.21	3.26	1.58	0.90	1.46	0.23	0.23	0.23	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	4359.71	61.00	12.28	10.59	4.24	0.85	2.54	2.97	2.54
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	4632.62	11.85	2.54	3.81	1.27	1.27	1.27	0.85	0.00
stomach, fetal, donor1	10062-101H8	2915.57	8.54	1.07	7.48	2.14	1.07	3.20	1.07	0.00
submaxillary gland, adult	10202-103F4	1533.58	28.48	9.68	5.13	3.42	0.57	1.71	1.71	1.14
substantia nigra - adult, donor10196	10178-103C7	1682.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	1060.34	8.93	3.95	1.66	1.45	0.62	0.42	0.42	0.83
substantia nigra, adult, donor10258	10371-105G2	1931.93	15.00	0.00	3.62	0.52	0.00	0.00	0.52	1.55
substantia nigra, newborn, donor10223	10358-105E7	1789.05	19.08	2.83	1.41	4.24	0.00	1.41	0.71	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	3754.22	7.80	3.90	0.46	3.67	0.92	0.00	0.46	1.15
temporal lobe, adult, pool1	10031-101E4	2465.72	8.22	2.46	2.20	1.44	0.42	0.68	0.85	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	5062.08	54.84	40.60	12.82	19.94	5.70	4.99	4.27	4.27
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	5388.30	70.33	25.05	8.79	14.50	2.64	2.64	1.32	5.27
tenocyte, donor1	11763-123H8	6199.68	90.42	26.88	10.47	7.33	5.24	5.59	5.24	1.75
tenocyte, donor2	11765-123I1	4359.46	46.93	5.34	8.39	5.34	3.05	2.67	1.91	1.53
tenocyte, donor3	11768-123I4	4327.15	61.90	8.90	4.08	4.08	2.22	4.82	1.85	1.48
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	7112.17	28.04	7.99	5.44	8.16	3.40	1.70	2.55	1.70
teratocarcinoma cell line:NCR-G1	10798-110I6	2493.35	20.66	6.94	3.85	6.01	1.85	2.16	1.70	1.08
teratocarcinoma cell line:PA-1	10807-111A6	5978.58	19.06	8.68	5.73	6.97	2.79	2.17	1.39	1.08
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	8355.55	49.89	12.06	8.51	10.79	6.47	2.03	3.05	2.29
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	5275.13	26.85	5.67	0.76	3.78	0.76	1.51	0.76	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	3276.56	18.00	1.20	1.96	2.07	1.20	0.55	0.22	0.87
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	2610.18	42.34	10.75	4.23	2.61	2.93	0.33	1.30	1.95
testis, adult, pool1	10026-101D8	2399.35	48.53	7.73	6.44	4.08	4.29	0.86	2.04	0.86
testis, adult, pool2	10096-102C6	1996.05	37.44	9.47	4.51	2.26	0.90	1.35	0.90	3.16
thalamus - adult, donor10196	10168-103B6	1972.82	17.66	5.52	2.21	3.31	0.00	1.10	0.00	1.10
thalamus, adult, donor10252	10154-103A1	1091.32	8.75	3.28	1.88	2.19	0.31	0.47	1.72	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	5625.76	6.16	3.08	0.00	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	1258.23	16.96	5.11	5.27	1.15	2.14	1.48	2.64	0.66
thalamus, newborn, donor10223	10366-105F6	2155.72	24.74	9.21	2.30	5.18	0.58	0.58	0.00	1.15
throat, adult	10209-103G2	2246.78	36.45	20.97	5.49	8.74	2.50	0.75	1.50	1.25
throat, fetal, donor1	10061-101H7	2157.62	30.17	10.97	7.31	7.92	0.91	0.91	0.91	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	3337.70	11.73	3.58	1.19	1.39	1.79	1.19	0.20	0.20
thymus, adult, pool1	10027-101D9	7119.60	71.68	8.65	6.06	7.26	6.46	1.79	3.58	1.29
thymus, fetal, pool1	10043-101F7	4282.11	17.77	3.53	3.12	2.91	2.08	1.45	1.04	0.73
thyroid carcinoma cell line:KHM-5M	10776-110G2	5814.90	25.66	6.25	2.93	4.12	1.99	1.86	1.86	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	4444.82	15.23	7.12	5.17	6.29	2.93	2.24	1.68	0.70
thyroid, adult, pool1	10028-101E1	2355.50	13.62	4.20	2.33	2.33	1.49	0.93	1.21	0.28
thyroid, fetal, donor1	10060-101H6	1969.56	20.04	7.91	2.90	3.69	1.58	0.79	0.53	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	1087.10	0.00	6.16	3.08	0.00	3.08	0.00	3.08	0.00
tongue, adult	10203-103F5	3944.98	74.42	14.65	6.05	6.05	5.35	3.72	2.56	5.12
tongue, fetal, donor1	10059-101H5	2425.64	24.04	11.43	3.94	5.12	2.76	1.58	1.58	1.18
tonsil, adult, pool1	10047-101G2	5192.30	12.92	3.51	2.00	2.60	1.00	1.00	1.40	0.80
trachea, adult, pool1	10029-101E2	3580.41	22.66	4.25	3.68	2.21	2.21	0.82	0.57	0.25
trachea, fetal, donor1	10058-101H4	1786.52	23.47	8.46	3.85	4.62	1.54	1.15	1.92	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	5284.73	25.15	12.40	9.21	9.21	3.54	2.13	1.06	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	4444.86	10.94	2.33	1.11	1.62	1.32	1.01	0.51	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	5083.71	29.14	6.42	1.88	6.74	3.60	1.57	1.25	0.47
tridermal teratoma cell line:HGRT	10694-109G1	5698.08	5.71	7.61	0.00	5.71	1.90	1.90	1.90	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	6342.52	18.28	4.74	2.96	4.66	1.95	1.19	0.68	0.68
umbilical cord, fetal, donor1	10057-101H3	2614.39	18.78	4.17	2.09	6.26	2.09	2.09	0.00	2.09
uterus, adult, pool1	10100-102D1	4023.76	14.50	2.73	2.22	1.37	1.54	1.19	0.51	0.17
uterus, fetal, donor1	10055-101H1	4135.36	38.91	20.48	9.73	5.63	3.58	3.07	4.10	3.07
vagina, adult	10204-103F6	1190.30	18.74	2.58	3.88	1.29	0.65	0.65	0.00	0.00
vein, adult	10191-103E2	2343.23	49.98	14.91	3.95	3.95	2.41	1.53	1.53	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	4387.95	17.89	8.81	6.41	4.54	2.40	1.87	1.87	1.07

Property "Nearest transcripts" (as page type) with input value "ENST00000644774.2:1 BC015779:2 BC001920:9 ENST00000681842.1:-10 ENST00000576544.6:-14 ENST00000574671.6:-14 ENST00000576214.3:-14 ENST00000679410.1:-14 ENST00000572105.7:-14 ENST00000679535.1:-14 ENST00000679480.1:93 ENST00000680727.1:260 BT019856:410 DQ891374:410 KJ896370:410 KJ905681:410 KR711165:410 KR711166:410 KR711167:410 KR711168:410 EU176631:410 EU832621:410 EU832693:410 KJ904414:410 CU676328:410 CU680176:410 BC063495:419 DQ589977:432 BC004223:433 BC017450:459" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.